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CHAPTER I 
 
INTRODUCTION 
 
Overview 
 Recovery from acute kidney injury (AKI) caused by a nephrotoxic insult requires 
renal tubule cell regeneration. The AKI can be induced by a toxic insult to the nephron 
following acute or chronic exposure to an environmental and/or occupational toxin, by 
ischemia/reperfusion (IR) injury typically induced by transient hemodynamic shock, or 
from treatment with chemotherapeutic and/or immunosuppressive drugs. The mechanism 
of repair from AKI is not clear.  
 The NFAT proteins are dynamic regulators of transcriptional activity and were 
first identified in T cells where their activation is a critical component in the initiation of 
an immune response. Cyclosporine A (CsA), an immunosuppressive drug inhibits the 
phosphatase activity of calcineurin thus preventing the dephosphorylation of NFATc1 
proteins necessary for the transcriptional activity of NFAT proteins. A clinical side effect 
of CsA is nephrotoxicity having both acute and chronic effects on renal structure and 
function. However, a mechanism has not been identified for the nephrotoxicity of CsA.  
 Extensive work has been performed to characterize NFAT expression and 
signaling in T-cells, the cardiovascular system, and numerous other tissues where roles 
for NFAT proteins have been described in controlling the cell cycle and activating 
transcriptional targets. In contrast, very little is known about the expression of NFAT 
proteins in renal tissues. Our laboratory made the novel observation that a member of the 
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nuclear factor of activated T cells (NFAT) family of transcription factors, NFATc1, is 
expressed in a subset of proximal tubule epithelial cells (PTC) following AKI. In 
addition, using a transgenic reporter mouse utilizing NFATc1 regulatory elements, 
expression was observed in the cortical region of the adult kidney. Our lab has previously 
described an important role for NFATc1 plays in maintaining the endocardial phenotype. 
Therefore, we hypothesize that NFATc1 might play a role in maintaining the epithelial 
phenotype of proximal tubule epithelial cells (PTCs). 
 The primary focus of my research has been to determine the function of NFATc1 
in PTCs in a mouse model of AKI in both normal tissue and during AKI. In Chapter I, I 
will discuss 1) the proposed models for tubular epithelial repair, 2) the regulation of 
NFAT transcription and function in the kidney, and 3) AKI and the nephrotoxicity of 
CsA and mercuric chloride (HgCl2). The first experiment that I performed in the kidney 
was to induce AKI with a single dose of HgCl2 in WT and in Nfatc1+/- mice over a brief 
time course. This experiment was the basis for the work described in Chapter II of this 
dissertation where I demonstrate that the Nfatc1+/- mice have sustained AKI, reduced 
expression of NFATc1, and increased proximal tubule apoptosis compared to WT mice. 
To further attenuate NFATc1 expression, Cyclosporine A was administered to mice and 
resulted in increased serum creatinine concentration, increased apoptosis, and reduced 
proximal tubule cell proliferation following HgCl2 injury as described in Chapter III. 
Chapters IV focus on the use of a novel NFATc1 transgenic lines to demonstrate 
accentuated NFATc1 expression in a subpopulation of proximal tubule cells following 
HgCl2 injury and Chapter V on the isolation and characterization of this unique 
subpopulation of proximal tubule progenitor cells (PTPCs). Further lineage analysis 
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documented that the NFATc1 labeled PTPCs are resistant to apoptosis and subsequently 
proliferate to repair the damaged proximal tubule segment and thus represent a progenitor 
population. In Chapter VI, I will conclude with a discussion of the significance of a self-
renewing resident PTC progenitor population and suggest future experiments to further 
characterize the role for NFATc1 in proximal tubule regeneration.  
 
Kidney structure 
 An adult human kidney is comprised of greater than one million individually 
functioning units called nephrons [Fig. 1.1. (McKinley and O'Loughlin, 2006)]. Each 
nephron contains a glomerulus and a segmented renal tube. The glomerulus purifies and 
filters the blood and is composed of Bowman’s space, capillaries, glomerular basement 
membrane, podocytes, and mesangial cells. The glomerular capillaries are composed of a 
network of fenestrated endothelial cells that create pores for plasma filtration. Mesangial 
cells have a phagocytic function and are located within the extracellular matrix between 
capillaries. The glomerular basement membrane maintains the structure of the glomerulus 
by fusing the basal lamina of the capillary endothelial cells with podocytes. Podocytes 
have interdigitating processes that cover the external side of the glomerular basement 
membrane and control the filtration of proteins from the capillary lumen into Bowman’s 
space, the portion of the glomerulus connected to the lumen of the renal tubule.  
 The glomerulus begins the formation of urine by filtrating plasma into Bowman’s 
space through the glomerular capillary wall into the adjacent processes that are separated 
by slit pores within the slit diaphragm. The filtration barrier established by the slit 
diaphragm  allows  water  and  small  plasma  solutes to pass through the filtration barrier  
Figure 1.1. Nephron structure. Figure adapted from McKinley and
O’Loughlin’s Human Anatomy (2006).
4
Proximal straight tubule (S3)
Proximal convoluted tubule (S1,S2)
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easily and restricts large proteins from being excreted into the urine through the renal 
tubule.  
 The renal tubule absorbs nutrients and water, concentrating the toxins. The renal 
tubule connects the Bowman’s capsule to the ureter and is made up of the proximal 
tubule, loop of Henle, and the distal tubule. The proximal convoluted tubule (S1, S2) is 
comprised of cuboidal epithelial cells with round nuclei and a luminal brush border 
composed of microvilli. The proximal tubule is located within the kidney cortex and 
actively reabsorbs water, NaCl, glucose, amino acids, and vitamins. Continuing from the 
proximal convoluted tubule is the proximal straight tubule (S3). The proximal tubule is 
followed by the loop of Henle that is composed of the thick descending limb, thin 
descending limb, thin ascending limb, and thick ascending limb. The thick and thin 
segments are comprised of cuboidal and squamous epithelium, respectively and functions 
to further concentrate the urine by removing water and NaCl.  The distal convoluted 
tubule is lined with cuboidal cells that have distinct lateral borders and lack a brush 
border. The distal tubule reabsorbs sodium and empties into the collecting ducts found in 
the medulla that further reabsorbs water and excretes urine into the ureter. 
 
Acute Kidney Injury 
Acute kidney injury (AKI, also called acute renal failure, acute tubular necrosis, 
and acute renal injury) is an important clinical problem resulting from insults that cause 
functional and structural changes in the kidney. The insult leading to AKI can be induced 
by a toxic insult to the nephron following acute or chronic exposure to an environmental 
and/or occupational toxin, treatment with chemotherapeutic and/or immunosuppressive 
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drugs, or by ischemia/reperfusion (IR) injury typically induced by transient 
hemodynamic shock (Basile, 2007). AKI is characterized by apoptosis of cells in the 
straight portion of the proximal tubular and thick ascending limb of the loop of Henle and 
is associated with changes in the serum chemistry and urine with increased 
concentrations of serum creatinine, blood urea nitrogen (BUN), and increased expression 
of kidney injury molecule 1 (KIM1) in tubule epithelial cells. If the injury stimulus is 
removed or inhibited the injury phase is followed by partial or complete regeneration of 
injured tubules.  
 
Models of AKI 
To identify mechanisms of renal injury, AKI is modeled in rodents by 
administration of renal toxins or surgical manipulations that mimic clinical nephrotoxic 
ischemia. Cisplatin, a chemotherapy drug used to treat pediatric and adult patients, 
induces renal injury of tubular cells marked by apoptosis and necrosis. A single injection 
of Adriamycin causes acute glomerular injury and loss of podocytes as well as tubular 
cell injury and progressive renal failure. A number of heavy metals of unknown 
biological function (cadmium, chromium, mercury, lead, uranium) excessive 
concentration of metals with known biological function (cobalt, copper, iron, zinc) and 
those used in chemotherapeutic drugs (platinum, vanadium) are accumulated in the 
proximal tubule and cause AKI (Sabolic, 2006). Ischemia/reperfusion is a surgical model 
of AKI performed by applying a temporary clamp on the renal pedicle, blocking the flow 
of blood for a short period of time under anesthesia followed by the release of the clamp. 
The AKI of ischemia/reperfusion injury is marked by vasoconstriction, hypoxic injury to 
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the microvascular endothelial cells and tubular epithelial cells, and leukocyte-mediated 
cytotoxicity. The cellular injury from ischemia/reperfusion injury is accompanied by 
depletion of ATP and an increase in intracellular Ca2+ and mimics the 
ischemia/reperfusion injury that occurs during kidney transplantation. During the process 
of renal transplantation, there is a period of anoxia during cold preservation followed by a 
period of reperfusion after implantation resulting in significant injury to the transplanted 
organ (Foley and Chari, 2007).   
The body of literature published documenting causes of, treatments for, and 
prevention of AKI is extensive. Therefore, I will focus the presentation on two forms of 
nephrotoxicity that are relative to this dissertation: nephrotoxicity induced by exposure to 
inorganic mercury (presented below) and nephrotoxicity associated with the 
immunosuppressive drug CsA (presented in the following section).  
 
Mercury nephrotoxicity 
 All forms of mercury, elemental and organic and inorganic conjugates, are toxic 
with inorganic mercury being more acutely nephrotoxic. Organic forms of mercury, 
including methylmercuric chloride and dimethylmercury, are less nephrotoxic and require 
multiple exposures to large doses in order to cause renal injury (Zalups, 2000). Inorganic 
mercury conjugates are more toxic and a single dose of mercuric chloride (HgCl2) causes 
AKI in mice and rats causing a marked injury in the PTCs preferentially in the S2 and S3 
segments (Hultman and Enestrom, 1986).  
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Cellular uptake of mercury 
 Mercury is transported into PTCs by interacting with thiol-containing compounds 
transported into the cell. There are two mechanisms involved in the uptake of mercury by 
PTCs: luminal membrane transport and basolateral membrane transport. At the luminal 
membrane, γ-glutamyltransferase and cysteinylglycinase import mercury conjugates of 
glutathione and cysteine, in particular dicysteinylmercury into the cell. At the basolateral 
membrane, the dicarboxylate and organic anion transport systems import mercury 
conjugates of cysteine, glutathione, homocysteine, and N-acetylcysteine into the cell. 
Mercury conjugated molecules interfere with subsequent metabolism causing changes in 
heme metabolism, lipid peroxidation, mitochondrial dysfunction, and oxidative stress. 
Renal tubular injury was increased in animals when they were administered a mercuric 
conjugate of cysteine (Zalups and Barfuss, 1996). Transportation, accumulation, and 
excretion of mercury containing molecules appears to be a mechanism exclusive to the 
proximal tubule as other segments of the nephron have not been shown to have a similar 
mechanisms (Zalups, 2000). 
 
Indices of injury 
 Depending on the form and dose of mercury administered, cellular injury and cell 
death can be detected along the length of the proximal tubule segment and cortex from 
beneath the outer capsule to the junction with the outer medulla (Zalups, 2000). During 
the early stages of mercury toxicity, proximal tubule cells undergo a number of structural 
changes including the shortening and lose brush border microvilli, detachment of cells 
from the basement membrane, blebbing, vesiculation of cytoplasm, derangement of the 
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cytoskeleton, cellular swelling, lysosomal swelling, and mitochondrial injury including 
vacuolation and fragmentation [Rev. in (Sabolic, 2006)]. Injury can be observed after 1 
hour, particularly after exposure to a high dose, and the peak in injury occurs at 24 hours 
and lasts roughly 3 days. Following injury, the proximal tubule is regenerated and 
function is restored within 2 weeks. Death from exposure to a high dose of inorganic 
mercury is due to AKI as well as cardiovascular collapse, shock, and severe 
gastrointestinal damage and bleeding. 
 The cellular response to injury from exposure to HgCl2 injury results in necrosis 
or apoptosis. Apoptosis resulting from AKI occurs from both the intrinsic mitochondrial 
pathway and from the extrinsic death-receptor pathway (Foley and Chari, 2007). 
Following cellular uptake (as described above), the cell is exposed to oxidative stress 
measured by the increased production of free radicals and the accumulation of reactive 
oxygen species, leading to the accumulation of intracellular cytoplasmic Ca2+. Synergistic 
action of reactive oxygen species and Ca2+cause mitochondrial damage and loss of 
mitochondrial function and in turn activates the cleavage of procaspases into active 
caspases. If the mitochondria are able to maintain the production of ATP as injury 
persists, the cell proceeds to undergo apoptosis. If production of ATP is inactivated 
and/or ATP stores are depleted, the cell undergoes cellular death by necrosis. Cells in the 
proximal tubule segment that do not undergo cell death launch a number of effects that 
favor cell survival including the activation of antiapoptotic proteins and induction of a 
number of protective proteins that decrease the injury caused by the oxidative stress and 
free radicals.  [Rev. in (Sabolic, 2006)].  
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Strain sensitivity 
 The nephrotoxicity of inorganic mercury varies between different inbred strains of 
mice. Mice on the C57BL/6 background are less sensitive to inorganic mercury exposure 
than mice on the 129/Sv, C3H/He, B6C3Fi, and Balb/c backgrounds. Mice on the 
C57BL/6 background are able to tolerate exposure to higher doses of HgCl2 without 
elevating serum creatinine and/or BUN concentrations and C57BL/6 mice excreted 
greater amounts of mercury in urine compared to other backgrounds (Satoh et al., 1997; 
Tanaka-Kagawa et al., 1998; Yasutake and Hirayama, 1986).  
 
Questions about mercury nephrotoxicity 
 There are a number of questions about mercury toxicity that are not addressed in 
the literature. How is the remaining toxicity handled by nephrons with denuded proximal 
tubule segments and an overall reduction of functioning nephrons? How do damaged 
nephrons regenerate PTCs? Are there resident cells, either proximal tubule or of another 
cell type that replace them via proliferation and/or dedifferentiation or a circulating cell 
of hematopoietic origin that repairs the nephron? The following section will cover the 
proposed role of circulating and resident stem cell populations in repairing the damaged 
kidney. 
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Mechanisms of proximal tubule epithelial repair 
 
Stem cells verses progenitor cells 
 Following AKI, it is necessary for the proximal tubule segment to repair itself in 
order to restore renal function and avoid complete renal failure. The cell population 
responsible for repair has been proposed to be either a stem cell or a progenitor cell. Stem 
cells are pluripotent, self-renewing, slow cycling, undifferentiated and reside in a stem 
cell niche – a microenvironment that directly promotes the maintenance of the stem cell 
population. The stem cell niche may be a great distance from the tissue in which they are 
active, as in bone marrow derived stem cells or the niche may be in close contact to the 
tissue and cell types in which they sustain and repopulate, such as stem cells located in 
hair follicles and intestinal crypts. In contrast, progenitor cells are differentiated, amplify 
transiently to undergo self-renewal, and cycling is dependent on the rate of proliferation 
necessary to either maintain or replenish the population [Rev. in (Morrison and 
Spradling, 2008)]. 
 There are three proposed mechanism for how proximal tubule repair occurs (Fig. 
1.2). One model suggests that bone marrow stem cells (BMC) circulating within the 
blood are able to incorporate and dedifferentiate into PTCs. A second model suggests that 
adjacent less injured mesenchymal cells in the interstitium undergo the process of 
mesenchymal to epithelial transition (MET) in order to repair the proximal tubule. A third 
mechanism suggests that it is the proximal tubules themselves that proliferate to repair 
and restore renal function.  I will discuss the literature supporting each of these proposed 
models. 
Injury
Injured
Tubule
A. B. C.
Figure 1.2. The origin of tubule epithelial progenitors. Following AKI, the
proximal tubule segment regenerates to restore renal function and prevent renal
failure. There are three proposed mechanisms for repair. A. One model
suggests that BMCs circulating within the blood dedifferentiate and incorporate
into the proximal tubule. B. A second model suggests that adjacent interstitial
cells undergo the process of mesenchymal to epithelial transition (MET) in
order to repair the proximal tubule. C. Finally, regeneration may occur via
proliferation of intrinsic self-renewing proximal tubule progenitor cells.
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Circulating progenitor cells 
 BMCs specifically hematopoietic stem cells (HSC) have been shown to be able to 
differentiate into numerous nonhematopoietic cell types. BMCs have been shown to 
localize to the kidney following a renal injury and have been identified as podocytes, 
endothelial, interstitial, mesangial, and tubular epithelial cells. Three mechanisms are 
proposed to describe the differentiation and incorporation of bone marrow derived stem 
cells into the host kidney. One, a subset of the BMC are pluripotent and able to 
differentiate into any cell type by responding to environmental signals. Two, BMC fuse 
with injured cells, providing undamaged cytoplasmic components, and form either 
synkaryons (one nucleus in a common cytoplasm) or heterokaryons (two nuclei in a 
common cytoplasm). And in a third proposed mechanism, cells do not undergo a 
proliferative process but instead transdifferentiate by epigenetic reprogramming into the 
new cell type, however, little evidence has been shown to support this important 
possibility. The therapeutic potential repairing renal damage via BMC transplantation 
BMC has been studied by injecting crude male BMC suspensions into female 
immunocompromised mice or rats. 
 Fusion of BMC with ES cells in vitro occurs at a ratio of 1 to 106 BMC. In vivo, 
fusion has been shown to occur in a number of tissues, including the chronically injured 
kidney, in which the proximal tubule was shown to be repopulated by fusion of donor 
BMC with host proximal tubules (Held et al., 2006).  Fusion events can be demonstrated 
by fluorescent in situ hybridization (FISH) to identify the presence of the Y chromosome 
of the donor male in female recipient. If male donor BMC are injected into an 
immunocompromised female host, a fusion event between the male BMC and an existing 
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renal cell would result in a change in the karyotype of the nuclei containing 2X1Y or 
3X1Y.  
 Lin and colleagues used a sophisticated genetic approach and injected male BMC 
of R26R-EYFP genetic background (Srinivas et al., 2001) into immunocompromised 
female hosts with a Ksp-Cre background. Ksp-Cre is a transgenic line that expresses Cre 
using regulatory elements for the kidney specific protein (ksp) cadherin and is expressed 
in tubular epithelial cells as well in other epithelial cells in the developing urinary/genital 
system (Shao et al., 2002). This genetic approach allows for fusion events to be identified 
in tubules cells not only by FISH but also by the identification of cells that express 
yellow fluorescent protein (YFP). The injected BMCs express YFP due to a floxed stop 
codon that prohibits reporter expression and in the presence of Cre, the stop codon is 
removed and YFP expressed. Using this technique, FISH was used to identify BMC that 
incorporated into collecting ducts, distal tubules, proximal tubules, and thick ascending 
limbs of female recipients following I/R injury. They identified that 1.8% of the tubular 
epithelial cells were bone-marrow-derived 4 weeks after injury. Extensive quantification 
revealed that 0.93% and 0.34% of these BMC underwent fusion and were identified to 
have karyotypes that were 3X1Y and 2X1Y, respectively. Immunolabeling with an anti-
YFP antibody showed that YFP was expressed in renal tubules, however the authors did 
not quantify the frequency of YFP expressing fused cells (Li et al., 2007a). Fusion events 
resulting in YFP expression in non-tubular cell types could not be detected due to limited 
expression of Ksp to renal tubules. While these experiments are novel and show evidence 
that a small number of tubular epithelial cells are repaired by fusion with BMC following 
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I/R injury, they would have been more informative in defining of the potential of fusion 
of BMC if the host expressed a ubiquitous Cre and if the YFP was observed real time.  
 Duffield and colleagues used three models of transplantation to create chimeras. 
Female mice were lethally irradiated and bone marrow was replaced with bone marrow 
from male mice, or bone marrow that would constitutively express GFP or constitutively 
express β-Gal. Six weeks after bone marrow replacement, mice underwent unilateral I/R 
injury. They identified an increase in BMC in the interstitium but not in tubular epithelia 
of the I/R injured kidney. BMC-derived cells were not observed in the contralateral 
uninjured kidney. BMC that appeared to be tubular epithelia were shown by 
deconvolution microscopy to be interstitial cells. Duffield and Bonventre explain that 
previous researchers did not use such sensitive microscopy and BMC-derived tubular 
epithelia described previously were misidentified (Duffield and Bonventre, 2005).  
 Bi et al. cultured bone marrow stromal cell (BMSC) and adipocyte derived 
stromal cells (AdSC) and injected them into mice following cisplatin induced AKI. 
BMSC and AdSC did not incorporate into regenerating renal tissue but did show that 
treatment with these cells reduced renal injury as measured by BUN concentrations. They 
suggested that the increased renal function was accredited to cytokines secreted by 
BMSC and AdSC that inhibit cisplatin-induced apoptosis and could be used clinically to 
increase renal function but not permanently repair the kidney (Bi et al., 2007). Thus the 
work by Duffield and colleagues and by Bi and colleagues suggests a limited direct 
therapeutic potential of BMC by their incorporation into or fusion with renal tubule 
segment of the nephron but rather suggests the major benefit was from paracrine 
signaling events. 
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Adjacent less injured cells 
 The mammalian kidney forms through the process of mesenchymal to epithelial 
transition (MET). The definitive mammalian kidney arises at day 35-37 of human 
gestation (embryonic day 10.5-11 in mouse) when a population of cells at the caudal end 
of the Wolffian duct known as the ureteric bud grows out into the surrounding 
metanephric mesenchyme. Reciprocal signaling events between the ureteric bud and 
metanephric mesenchyme allow the ureteric bud to branch and the metanephric 
mesenchyme to condense. Condensed metanephric mesenchyme at the tips of the ureteric 
branches undergo MET to form the proximal and distal tubules of the nephron and 
epithelial component of the developing glomerulus. Migrating endothelial cells form the 
remainder of the glomerulus and the ureteric branch develops into the collecting duct. 
Development of the kidney is unique in that mobile and unorganized mesenchymal cells 
receive signals to form organized polarized epithelia with distinct adhesion properties to 
undergo MET (Vainio and Lin, 2002). The second proposed mechanism for tubule repair 
is based on a recapitulation of normal renal developmental processes marked by 
dedifferentiation and migration of adjacent uninjured or less injured cells into damaged 
epithelial tubules by MET. Because transgenic markers have not been identified, this 
hypothesis is tested using a common experimental design: sorted or cultured cell 
populations are labeled with a tracer molecule, such as a fluorescent protein, and 
reintroduced into the kidney via engraftment under the renal capsule or injection into the 
blood stream.   
 Little and colleagues studied side population (SP) cells in the adult kidney and 
their ability to integrate into regenerating tissue. SP cells are proposed to be a resident 
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progenitor population of cells and were identified by retaining low levels of Hoechst 
fluorescent dyes because their membrane transport pumps can efflux the dye rapidly out 
of the cell. FACS analysis showed that SP cells account for 0.14% of the adult kidney 
and are further characterized to be CD45-, CD34-, c-kit-, Sca1+, CD24+ and CD31+. 
This expression pattern distinguishes SP cells from bone marrow SP cells, which are 
CD45+, CD34+, c-kit+, Sca1+, CD24+ and CD31+. AKI was modeled by a single 
injection of Adriamycin, which causes acute glomerular injury and loss of podocytes as 
well as tubular cell injury and progressive renal failure. After injecting Adriamycin into 
the tail vein to induce AKI, isolated adult kidney SP were injected both directly under the 
kidney capsule and into the circulatory system via the renal vein. SP cells incorporated 
into proximal tubule, distal tubule, collecting duct, glomerulus, and interstitium but not 
into endothelial cells of the blood vessel. The authors used microarrays to identify a set of 
additional markers that were upregulated in SP of adult and embryonic kidney samples 
compared to adult kidney. In situ hybridization was used to confirm expression of those 
markers and identify a cell population that expressed these cells. Most of the identified 
markers were expressed in proximal tubules and interstitial cells with the exception of 
CD24 that was not expressed in proximal tubules (Challen et al., 2006). The SP cells 
show potential to be a stem cell population because they were able to incorporate into 
multiple cell types thus demonstrating multipotency, however the endogenous location of 
these cells is unclear due to the inability to identify a specific population that expressed 
the predicted markers. Yet it is unclear whether incorporation of the injected SP was due 
to cells that were circulating in the blood or due to injection under the renal capsule. The 
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identification of the cells in the interstitium suggests that a role for regeneration via an 
adjacent cell population. 
 Al-Awqati and colleagues propose the renal papilla as the niche for adult renal 
stem cells and following AKI these cells migrate and repair damaged tubules. They 
pulsed 3-day-old neonatal rats with the thymidine analog bromodeoxyuridine (BrdU) for 
3.5 days and examined retention of the label after 2 months. The mitotic interval for cells 
during early ex utero development was 3 days and thus all cells would label with BrdU 
during the pulse. During the 2 month chase, cells that were rapidly dividing would reduce 
the individual cell chromatin labeling with BrdU to levels that would not be able to be 
detected and cells retaining the label were slow-cycling stem cells are called “label-
retaining cells”. They found that the renal papilla contained an abundant population of 
cells that retained a strong BrdU signal. However, these cells disappeared from the 
papilla following I/R injury despite the finding that the papilla did not undergo apoptosis 
after injury. These cells were not incorporated into the recovering renal tissues and the 
authors proposed that these cells migrated into the damaged regions of the nephron and 
underwent multiple rounds of proliferation, thus reducing the level of BrdU to a level that 
cannot be detected (Oliver et al., 2004). Thus the proposed mechanism for tubule repair is 
through the uninjured niche of papilla stem cells. However, the authors did not document 
evidence of a genetic marker that would allow lineage tracing or evidence showing 
observations of migration of these cells Furthermore, due to the high osmotic stress that 
renal papillary cells are exposed to, the label retention of BrdU may result in artifact 
labeling (Burg, 2002).  
 19 
 Goligosky and colleagues further studied the papilla stem cells using Nestin-GFP  
(green fluorescent protein) transgenic mice created by Mignone et al. (Mignone et al., 
2004) as a genetic marker. Nestin has been proposed to be a stem cell marker expressed 
by intraepithelial stem cells, mesonephric mesenchyme, and endothelial cells and in the 
adult kidney. In adult mice, Nestin-GFP was identified in the papilla as well as in the 
medulla, podocytes of the glomerulus, and in the parietal epithelial cells that line the 
Bowman’s capsule. They performed I/R and analyzed changes in Nestin-GFP expression. 
Nestin-GFP expression was enhanced in the glomerulus and peritubular capillaries, 
although the number of cells expressing GFP after I/R injury did not change. They 
observed the migration of GFP cells ex vivo and concluded that GFP cells in the papilla 
migrated toward the cortex. However, they did not observe expression of Nestin-GFP in 
proximal or distal tubules (Patschan et al., 2007). This study shows that Nestin expression 
is increased in endothelial-like cells following renal injury. The transgenic Nestin-GFP 
reporter is dependent on nestin regulation and it is proposed that as labeled cells begin to 
differentiate into epithelial like cells, they lose expression of nestin and therefore GFP 
expression. Lineage tracing performed with a nestin-Cre and the R26R-EYFP reporter 
would address this lingering question.  
 Multipotent renal progenitor cells (MRPC) were isolated from adult rat kidneys 
that were digested with collagenase (Gupta et al., 2006). MRPC were grown on 
fibronectin-coated plates for 4 to 6 weeks until spindle-shaped cells were formed and 
then plated at a single cell density to form individual colonies. Undifferentiated MRPC 
expressed CD90, CD44, vimentin, and Oct4 but did not express SSEA-1, CD-11b, CD45, 
CD133, CD106, MHC class I and II, CD31, CD56, and Cytokeratin. Undifferentiated 
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MRPC could be differentiated and induced to express endothelial, epithelial, hepatocyte, 
and neural markers. Undifferentiated MRPC were used in two in vivo models: injection 
under the renal capsule and injection following I/R injury. When injected under the renal 
capsule, MRPC formed cyst-like structures and tubular-like structures that no longer 
expressed Oct-4, a pluripotent stem cell marker, suggesting that these cells were 
differentiated. Rats were subjected to 30 minutes of ischemia followed by injection of 
MRPC into the abdominal aorta. MRPC were found in renal tubules at a frequency of 5-
10% and lodged in the glomeruli, an adverse effect that the authors attributed to the 
administration of the exogenous cells not observed in sham treated animals. However, the 
injected MRPC did not increase renal function over saline injected or sham operated rats. 
The authors conclude that MRPC are renal stem cells that can differentiate into renal 
tubules following injury despite the fact that they could not histologically mark 
endogenous MRPC in the rat (Gupta et al., 2006). 
 Romagnani and colleagues identified adult parietal epithelial multipotent 
progenitors (APEMP) located in Bowman’s capsule expressing stem cell markers CD24 
and CD133. They isolated these cells and injected them into adult severe combined 
immunodeficiency (SCID) mice with glycerol-rhabdomyolysis induced AKI and found 
that APEMP incorporated into proximal and distal tubules and increased renal function as 
seen by decreased BUN levels compared to SCID mice without injection of APEMP cells 
(Sagrinati et al., 2006). This suggests evidence for an adjacent less injured cell 
population, although genetic markers have not been identified to label APEMP in vivo to 
question whether or not they can migrate and differentiate into proximal and distal 
tubules.  
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 Romagnani and colleagues identified a population of human renal multipotent 
progenitor cells isolated from human embryonic kidneys (aborted fetuses) identified by 
markers for CD24 and CD133 (CD24+CD133+ REC, renal epithelial cells). In vitro, 
CD24+CD133+ REC were able to differentiate into adipogenic, endothelial, osteogenic, 
stromal, and epithelial cell types. When subcutaneously injected into SCID mice, 
CD24+CD133+ REC spontaneously formed vessel like structures that express the 
endothelial marker von Willebrand factor (vWF). The role of CD24+CD133+ REC in 
recovery from glycerol-rhabdomyolysis induced AKI was studied by injecting cells into 
the tail vein of SCID mice at the peak of renal injury. CD24+CD133+ REC incorporated 
into various renal cell types including, proximal tubule, distal tubule, collecting duct, and 
endothelial cells. Injection of these cells showed protection against renal injury, as BUN 
levels were decreased in mice treated with REC at the peak of injury and BUN levels 
were further reduced with administration of REC and glycerol concurrently (Lazzeri et 
al., 2007). This study suggests that CD24+CD133+ REC further differentiated in the in 
vivo host setting and migrated into injured tubule segments and support a mechanism that 
adjacent less injured non-tubular epithelial cell populations repair injured tubules.   
 
Self-renewal of PTCs 
 The final mechanism for proximal tubule repair is through proliferation of 
proximal tubule cells that survive the AKI. This model is the most difficult to prove 
because either a subset of regulatory markers specifically expressed by the proximal 
tubule progenitor cells and/or genetic markers are needed to show proliferation within the 
proximal tubule progenitor cell population.  
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  Evidence of tubular progenitor cells was examined in rats by investigating the 
cell cycle rate. Continuous BrdU labeling for 7 days showed strong nuclear labeling 
particularly in the S3 segment of proximal tubule cells. The labeling period was extended 
to 14 days rationalizing that the cell cycle time in various epithelia is 1-3 days and rapidly 
cycling transiently amplifying (TA) cells should have all gone through the cell cycle 
during the labeling period and thus should all be BrdU positive.  In order to identify 
slow-cycling cells, they performed immunohistochemistry with the Ki-67 marker to 
identify Ki-67+BrdU- cells. They expected all proliferating cells to pass though the S-
phase during the 14-day long BrdU labeling period and incorporate BrdU. If further 
labeling with the marker Ki-67 occurred, this would identify a cell that is Ki-67+ BrdU–, 
and that cell would be a slow cycling cell. They did identify Ki-67+BrdU- slow-cycling 
cells in the proximal tubule and these cells expressed proximal tubule markers suggesting 
that they were fully differentiated. The authors conclude that the proximal tubule is 
regenerated via division of differentiated slow-cycling cells and rapidly proliferating cells 
(Vogetseder et al., 2007). However, the authors did not question which of these 
populations of proximal tubules, slow-cycling or rapid-cycling cells, was responsible for 
regeneration following an injury stimulus.  
 A hypothesis has been proposed that the self-renewing proximal tubule progenitor 
cells are differentiated epithelia that can express embryonic stem (ES) cell markers. 
Testing this hypothesis, Vigneau et al. differentiated ES cells into embroid bodies in 
vitro. The cells were LacZ/T/GFP+ where LacZ was targeted into the ubiquitously 
expressed ROSA26 locus (R26R) and GFP was cloned into one allele of the mesodermal 
marker brachyury (T) locus. Thus, all cells will express β-Gal but only cells adopting a 
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mesodermal fate will express GFP. The LacZ/T/GFP+ cells were injected into 
developing newborn mouse kidneys and the LacZ/T/GFP+ cells integrated into proximal 
tubules with normal morphology and polarization. Mice that had received these ES 
derived cells did not form teratomas as adults, a concern when working with ES cells. 
These cells were further purified as renal proximal tubular progenitor cells and are 
proposed to be a major step towards clinical regenerative therapies (Vigneau et al., 2007). 
However, the therapeutic potential of these cells has ethical limitations because they are 
derived from ES cells Furthermore, based on the experiments performed, observations 
are limited to pediatric therapy as the authors did not perform experiments injecting these 
cells into adult mice with/without renal injury or identify brachyury expressing adult 
proximal tubules.  
 
Lessons from renal stem cells and progenitor cells 
 The work described in the preceding sections support multiple mechanisms for 
tubular repair: via differentiation of circulating bone marrow derived stem cells, 
proliferation and trans-differentiation of adjacent less injured non-epithelial cells, and 
intrinsic self-renewal progenitor proximal tubule cells. However the significance of each 
of these mechanisms is hindered by the lack of a genetic and/or transgenic model systems 
and proper lineage tracing paradigms to document the circulation, migration, and/or 
proliferation of the stem/progenitor cell population. These studies suggest further 
investigations of renal progenitor populations require development of genetic/transgenic 
model systems that would 1) label the progenitor cell population prior to and throughout 
the period of regeneration, 2) apply a permanent genetic mark by a reporter on the 
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stem/progenitor cell thus providing lineage tracing, and 3) be independent of cell 
phenotype thus not limiting expression to a specific cell fate allowing for observation of 
trans-differentiation. The studies presented in this dissertation will directly address some 
of these concerns.  
 
The NFAT family of transcription factors 
Nuclear factor of activated T cells (NFAT) are named for the T cells in which 
they were initially identified. The NFAT family of transcription factors contains five 
proteins that were initially thought to be specific regulators of cytokine gene activation in 
the immune system because they bound the interleukin-2 (IL-2) promoter in activated T-
cells (Crabtree, 1999; Crabtree and Olson, 2002; Hogan et al., 2003; Rao et al., 1997). 
Alternatively spliced forms have been identified for NFATc1, NFATc2 and NFATc4 and 
these splicing events allow for variation at the amino (N) and carboxyl (C) termini with 
the core region being conserved (Fig. 1.3a). All members of the NFAT family contain the 
NFAT homology region (NHR) and a highly conserved DNA binding domain, the REL 
homology region   (RHR), which   is the   unifying   characteristic of   NFAT   proteins 
establishing DNA binding specificity (Fig. 1.3b). The NHR is relatively conserved 
amongst family members and contains the transactivation domain, several serine residues 
that are phosphorylated in resting cells, and docking sites for calcineurin and the NFAT 
kinases, casein kinase 1 (CK1) and glycogen-synthase kinase 3 (GSK3β). The RHR links 
NFAT proteins to the REL-family of transcription factors also named the nuclear factor-
κβ (NF-κβ) family of transcription factors.  
 
Figure 1.3. The NFAT family of transcription factors. A. Isoforms of the
NFAT family of transcription factors. B. A schematic representation of the
transactivation, regulatory, DNA-binding and C-terminal domains of NFATc
proteins. This figure from Macian et al. (2005) is reprinted with permission
from the Nature Publishing Group, license number 1865010844872.
NFATc1
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NFAT signaling 
The NFATc proteins, NFATc1, NFATc2, NFATc3 and NFATc4, are regulated by 
calcium signaling (Fig. 1.4) (reviewed in (Crabtree and Olson, 2002; Macian, 2005). 
Phosphorylated NFATc proteins are localized in the cytoplasm and are transcriptionally 
inactive. Activation of NFATc proteins requires an influx of intracellular calcium. 
Receptor signaling, such as the activation of T cell receptor in T cells, activates 
phospholipase C-γ, which hydrolyzes phosphatidylinositol-4-5-bisphosphate to make 
inositol-1,4,5-trisphosphate (InsP3). InsP3 triggers the release of calcium from 
intracellular stores. This intracellular increase in calcium also triggers calcium-release 
activated calcium channels (CRAC) at the plasma membrane to open thus sustaining the 
increased intracellular calcium levels.  
Calmodulin binds calcium, in turn activating the calmodulin dependent 
phosphatase calcineurin forming an active phosphatase complex that dephosphorylates 
NFAT, exposes the nuclear localization sequence, and shuttles NFAT to the nucleus 
where it binds DNA targets at specific recognition sites. Calcineurin has two functional 
units; A contains the phosphatase domain and mediates interaction with phosphorylated 
substrates, and B binds calcium and calmodulin and, when bound to A, causes a 
conformational change that exposes the phosphatase domain of the A subunit. There are 3 
isoforms of calcineurin A, α, β, and γ and 2 isoforms of calcineurin B, 1 and 2. 
Calcineurin-Aα and -Aβ and calcineurin-B1 are ubiquitous. Calcineurin Aγ and 
calcineurin-B2 are found primarily in the testes with little expression in the brain (Rev. in 
(Gooch, 2006; Macian, 2005). 
Figure 1.4. Regulation of NFAT activation. Following an increase in
intracellular calcium, the active calcium-calmodulin-calcineurin complex
dephosphorylates NFAT allowing nuclear localization and subsequent
transcriptional activity. Calcineurin phosphatase activity is inhibited by
pharmacologic drugs, Cyclosporine A (CsA) and FK506 (tarcolimus).  This
figure from Steinbach et al. (2007) is reprinted with permission from the Nature
Publishing Group, license number 1873810550481.
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Nuclear export of NFATc, and thus transcriptional deactivation, is regulated by 
GSK3β and CK1. These kinases phosphorylate NFATc masking the nuclear localization 
sequence and facilitating nuclear export (Beals et al., 1997). Thus, transcriptional activity 
of NFAT is dependent on the phosphorylation state and a balance between nuclear import 
and export. Phosphorylation sites are found in serine-rich motifs: serine-rich region 1 
(SRR1) motif, serine-proline-X-X (SPXX) repeat motif (where X is any amino acid), and 
serine-proline 2 (SP2) and SP3. Calcineurin dephosphorylates 13 of the 14 conserved 
phosphorylation sites in NFATc proteins and dephosphorylation exposes the nuclear 
localization signal allowing nuclear transport of the NFATc proteins and may also control 
RHR DNA binding affinity. 
NFAT5, the tonicity element binding protein (TonEBP), does not contain these 
binding domains and is regulated by hypertonic/osmotic stresses (Huang and Rubin, 
2000; Lopez-Rodriguez et al., 2001; Lopez-Rodriguez et al., 1999; Miyakawa et al., 
1999). NFAT5 is expressed by almost every cell as it responds to changes in osmotic 
stress (Lopez-Rodriguez et al., 2001; Miyakawa et al., 1999). NFAT5 controls the 
osmotic stress-induced expression of several cytokines, including tumor necrosis factor 
(TNF) and lymphotoxinβ and NFAT5 null mice have impaired T-cell function under 
hyperosmotic stress conditions (Go et al., 2004; Lopez-Rodriguez et al., 2001). NFAT5 is 
the primordial member of the NFAT family and expression of this protein emerged as 
early as Drosophila by evolution from the REL-family of transcription factors and the 
NFATc proteins are thought to have evolved as mammals evolved and adopted the 
calcineurin regulatory domains (Stroud et al., 2002).  
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NFATc1 
Three isoforms have been identified for NFATc1 (Fig. 1.5). NFATc1/A is 
expressed using the P1 promoter and the polyadenylation site pA1. NFATc1/B and 
NFATc1/C are expressed using either the P1 or P2 promoter, have a truncated N-terminal 
with transcription starting with exon 2, a long C-terminal, and use the polyadenylation 
site pA2 (Chuvpilo et al., 1999). 
As described above, NFATc is regulated by calcium and calcineurin. However, 
NFATc1, more specifically the NFATc1α isoform, an N-terminal splice variant of 
NFATc1, is unique as transcriptional regulation also occurs via an autoregulatory loop 
requiring an NFAT-dependent inducible promoter. In T cells, when sufficient levels of 
constitutively expressed NFATc1 are attained, NFATc2 acts with NFATc1 to turn on 
expression of the inducible isoform of NFATc1 leading to persistent NFATc1 
transcriptional activation (Chuvpilo et al., 2002b; Zhou et al., 2002). 
Two research groups concurrently but independently created single-exon 
deletions of NFATc1 with the intentions of studying NFATc1 null T cells. The Nfatc1-/- 
allele created by Ranger et al. mutated the RHR and de la Pompa et al. mutated the NHR 
(de la Pompa et al., 1998; Ranger et al., 1998a).  In both cases, Nfatc1-/- embryos died in 
utero of cardiac valve and septal defects. These studies identified NFATc1 as the only 
NFAT member expressed in endocardial cells during valve development. The role of 
NFATc1 was further delineated in valve formation via endothelial to mesenchymal 
transition (EnMT). In the endothelial cells, NFATc1 expression was dephosphorylated 
and nuclear localized suggesting constitutive transcriptional activity. NFATc1 expression 
was  not   detected  in  the   mesenchymal  cells  that  fill  the  cushions  of  valves  of  the  
Figure 1.5. Model of transcription of NFATc1. Nfatc1 transcription is
controlled by two promoters, P1 and P2, and two poly A sites, pA1 and pA2.
The strong promoter P1 and the weak polyadenylation site pA1 control the
highly inducible transcription and autoregulation of the short isoform
NFATc1/A. The synthesis of the longer isoforms NFATc1/B and NFATc1/C is
controlled by either P1 or P2 and by the strong polyadenylation site pA2. The
autoregulation of P1 promoter by NFATc1 or NFATc2 results in an increase of
NFATc1/A but not NFATc1/B and/or NFATc1/C synthesis. Adapted from
Chuvpilo et al. (1999).
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developing out-flow track and atrial-ventricular canal (Ranger et al., 1998a). These 
findings suggested that NFATc1 signaling maintained the specificity of the endocardial 
cells.  
Unpublished work performed within the Baldwin laboratory has investigated the 
role of NFATc1 during cardiac EnMT, a necessary process for valve formation. Nfatc1-/- 
stem cells (Ranger et al., 1998b) were injected into WT blastocysts creating chimeric 
embryos. Quantification of the identity of cells within cardiac valves showed that 
chimeric valves had a decreased number of Nfatc1-/- endocardial cells and an increased 
number of Nfatc1-/- mesenchymal cells suggesting that Nfatc1-/- cells progressed to EnMT 
more frequently than WT cells. Therefore it was hypothesized that NFATc1 is at least 
partially responsible for maintaining the endocardial pro-valvular phenotype during 
development of the heart and may be responsible for establishing and maintaining the 
phenotype of other cell populations.  
 
NFATc1 expression in stem cells 
While preparing this dissertation, a role for NFATc1 was described in hair follicle 
stem cells. A microarray screen was performed to identify genes that are differentially 
expressed in the niche of stem cells of a hair follicle, the bulge, compared to the 
epidermis (Horsley et al., 2008). NFATc1 expression was identified in the quiescent 
bulge cells in the hair follicle. NFATc1 was shown to be involved in a mechanism to 
control stem cell cycling. NFATc1 expression is activated by bone morphogenic protein 
(BMP) signaling and represses cyclin dependent kinase 4 (CDK4) signaling in order to 
maintain stem cell quiescence and when the stem cells are activated to grow a hair, 
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NFATc1 is downregulated, removing the repression of CDK4 and allowing proliferation. 
Inhibition of calcineurin phosphatase activity using CsA (described below) increased hair 
growth, a phenotype that was also observed in calcineurin B1 null mice (Mammucari et 
al., 2005).  When Horsley et al. inhibited NFATc1/calcineurin signaling by deleting a 
conditional allele of NFATc1 or treated mice with CsA, the quiescent phase of the stem 
cell was removed resulting in rapid hair growth (Horsley et al., 2008). This was the first 
report for NFATc1 in a stem cell population, and shows that NFATc1 plays a functional 
role in maintaining the rate of proliferation in stem cells. 
 
Inhibition of NFATc signaling 
NFATc proteins have an important role in an immune response. Therefore, it is 
not surprising that inhibition of this family of proteins would have significant clinical 
implications in the treatment of patients with autoimmune diseases and improving the 
survival of grafted tissues. Identifying calcineurin inhibitors has been a major focus as a 
way of preventing NFAT activation. Synthesis of molecules that interfere with the 
interaction of NFAT and calcineurin has been possible due to structural analysis of this 
interaction. In the NHR, a conserved sequence PXIXIT (where X is any amino acid) has 
been identified as the calcineurin binding sequence. A similar peptide, VIVIT 
(MAGPHPVIVITGPHEE full length sequence), has a high affinity to this sequence and 
has been used to block NFAT dephosphorylation in vitro (Aramburu et al., 1999). In rats, 
VIVIT has been shown to be a potential therapeutic agent in treating several 
cardiovascular disorders including angiogenesis, atherosclerosis, cardiac hypertrophy, 
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and restenosis. Clinical trials with VIVIT are in preclinical stages and no patient data is 
currently available (Yu et al., 2007a).  
CsA and Tacrolimus (FK506) are pharmaceutical drugs that block phosphatase 
activity of calcineurin (Ho et al., 1996) thereby blocking nuclear translocation and 
function of all NFATc proteins. However, these drugs have unintended neurotoxic and 
nephrotoxic side effects (discussed below). The mechanistic cause for these side effects is 
thought to occur through the inhibition of unintended targets because they block 
calcineurin activity and not NFAT activity directly (reviewed in (Bechstein, 2000; Olyaei 
et al., 2001). A number of endogenous calcineurin inhibitors have been identified in 
recent years. These include the A-kinase anchor protein (AKAP), calcineurin-binding 
protein 1 (CABIN), and members of the Down’s syndrome critical region 
(DSCR)/modulatory calcineurin-interacting protein (MCIP) family of calcineurin 
inhibitors, known as calcipressins (Coghlan et al., 1995; Rothermel et al., 2000; Sun et 
al., 1998).  
 
Acute and chronic CsA nephrotoxicity 
CsA has been shown to have dramatically different cell specific effects on 
endothelial, epithelial, and fibroblast cells (Esposito et al., 2000b), thus the toxic effects 
of CsA are likely multifactorial. Adverse renal complications have been associated with 
CsA including nephrotoxicity, interstitial fibrosis, and decreased glomerular filtration 
rate. CsA has both acute and chronic effects on renal function.  
 Acute CsA nephrotoxicity causes injury in PTCs characterized by disrupted brush 
border and disrupted cytoplasm (Esposito et al., 2000b). CsA has an antiproliferative 
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response in endothelial and epithelial cells and is associated with initiation of apoptosis 
(Esposito et al., 2000a). Acute effects of CsA can also include glomeruloarteriolar 
constriction with a hemodynamically mediated decrease in the glomerular filtration rate 
directly related to endothelial injury (Gauthier and Helderman, 2000; Kahan, 1989).  
Vacuolization, degeneration and apoptosis of arteriolar smooth muscle cells are also part 
of the injury spectrum (Blair et al., 1982; Mihatsch et al., 1988).   
Chronic CsA nephrotoxicity is characterized by progressive renal dysfunction, 
concentric arteriolar hyalinization, inflammatory cell influx, glomerular scaring, 
increased intrarenal immunogenicity, and striped tubular interstitial fibrosis (Burdmann et 
al., 1994; Li et al., 2004; Myers et al., 1988; Young et al., 1995a; Young et al., 1995b), 
which has been shown to be initiated by epithelial to mesenchymal transformation (EMT) 
of the PTCs (Iwano and Neilson, 2004; Iwano et al., 2002). Chronic effects of CsA have 
been shown to inhibit the renin-angiotensin-aldosterone pathway, activate profibrotic 
genes, and maintain intrarenal ischemia causing cycles of injury and repair eventually 
culminating in kidney dysfunction seen in organ transplant recipients (Rezzani, 2004). 
Although several molecules have been identified that play a role in this disease process, 
the mechanism by which CsA causes acute and chronic nephrotoxicity is still poorly 
understood. Alternative immunosuppressive drugs have been identified and clinically 
tested but are not as effective as CsA. Thus, in the face of the nephrotoxic side effects of 
CsA, it is a necessary therapeutic drug. 
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NFAT and calcineurin expression in renal tissue 
NFATc proteins have been shown to regulate the development and function of a 
variety of cells and tissues including, components of the cardiovascular, immune, 
nervous, skeletal and vascular systems. However, information on the expression and 
function of NFAT proteins in renal cells received little attention in the literature prior to 
my dissertation research. I will focus now on publications prior to and during my thesis 
research documenting expression and function of NFAT and calcineurin in renal tissues. 
NFATc1 has been identified in glomerular mesangial cells, in vitro, where it 
regulates COX2 expression following increase in endothelin-1 (Sugimoto et al., 2001) 
and COX2 expression is suppressed following CsA treatment (Hocherl et al., 2002). 
However, expression of NFATc1 has not been observed in mesangial cells, in vivo, but 
has been shown to be predominantly expressed in cortical tubules using and anti-NFATc 
antibody (Gooch et al., 2003; Puri et al., 2004). However, the antibody used to document 
NFATc expression recognizes all NFATc proteins and does not distinctively label 
NFATc1.   
Li et al. analyzed the relationship between the calcium-dependent calcineurin-
NFATc pathway and NFAT5 in vitro in immortalized murine collecting duct principal 
cells (mpkCCD). They showed that NFAT5 and NFATc1 bound to NFAT binding 
sequences on the promoter of aquaporin-2 (AQ-2), a water channel protein specifically 
expressed in the distal tubule and collecting duct. Expression of AQ-2 increased in 
response to hypertonicity and increased intracellular calcium concentrations. The 
increased in AQ-2 is important in maintaining the transfer of water from the apical 
membrane of the collecting duct epithelial cells to the medullary interstitium when 
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interstitial osmolality increases. This allows collecting duct epithelial cells to respond to 
local changes in osmotic stress independent of the normal function of these cells to 
remove water and electrolytes when concentrating urine (Li et al., 2007b). In addition, 
rats treated daily with CsA had decreased expression of AQ-1 (a proximal tubule specific 
aquaporin), decreased expression of hypertonicity protective genes, and increased renal 
tubular apoptosis (Lim et al., 2004). These findings suggest that the chronic 
nephrotoxicity of calcineurin inhibitors in renal tubules may result from a defect in 
calcineurin-mediated regulatory mechanisms.  
NFAT5 is the only NFAT null allele documented to have a renal phenotype. 
NFAT5 knock out mice (Nfat5-/-) die in the late embryonic or perinatal period, though the 
etiology of death has not been delineated.  Some Nfat5–/– mice survive into early 
adulthood and have disrupted kidney morphology resulting from increased hypertonic 
stress including irregularly shaped tubules and epithelial cells, incomplete papilla 
formation, enlarged renal pelvis, and progressive atrophy of the medulla (Lopez-
Rodriguez et al., 2004). Cells within the medulla compensate for increasing extracellular 
hypertonic stress by increasing membrane transporters and enzymes that increase 
intracellular osmolites including aldose reductase, Na+/Cl- coupled betaine/γ-
aminobutyric acid transporter, and Na+ dependent myoinositol transporter, which were 
down-regulated in the kidneys of Nfat5–/– mice. NFAT5 was previously shown to 
maintain transcription of these enzymes and transporters in order to protect cells from 
hypertonicity. The severe renal abnormalities observed in Nfat5-/- mice that survived into 
adulthood show demonstrated reduced capacity of the epithelium to endure high osmotic 
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stress. However, NFAT5 activation, unlike NFATc proteins, is not dependent on 
calcineurin phosphatase activity, as described above.  
A floxed allele of calcineurin-B was deleted using a Pax3-Cre transgene. The 
Pax3-Cre transgenic mice have strong Cre expression in neural crest cells and is strongly 
expressed in the metanephric mesenchyme (Li et al., 2000). Calcineurin-B null mice had 
progressive renal obstruction that lead to renal failure and death (Chang et al., 2004a). 
Specific knockouts of calcineurin-Aα and calcineurin-Aβ had similar renal 
developmental defects. However, further inhibition of each knockout by treatment with 
CsA showed that CsA inhibition was specific to the Calcineurin-Aα isoform and 
reproduced features of CsA nephrotoxicity in vivo and in vitro.  [Rev. in (Gooch, 2006)] 
Calcineurin-Aα has been shown to be the main isoform expressed in the proximal tubule 
(Tumlin et al., 1995). This localization correlates with some of the indices of the 
nephrotoxic injury and interstitial fibrosis associated with CsA and may indicate 
disruption of NFATc function in the PTCs.  
 
Proposing a link for CsA, NFATc1 and nephrotoxicity 
 In lymphocytes, CsA inhibits calcineurin preventing the dephosphorylation and 
transcriptional activation of NFATc proteins. The benefits of CsA are equally meet by 
side effects such as nephrotoxicity, thus decreasing the therapeutic potential of CsA. One 
of the renal cell populations damaged by CsA-associated nephrotoxicity is the proximal 
tubule, in which expression of calcineurin-Aα, the isoform of calcineurin specifically 
targeted by CsA has been documented as well as expression of NFATc proteins (Gooch, 
2006; Puri et al., 2004). Therefore, one important questions remains: Is this mechanism 
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of disrupted calcineurin/NFATc signaling and transcriptional inactivation responsible for 
the immunosuppressive activity of CsA specific to lymphocytes or is disrupted 
calcineurin/NFATc signaling replicated in other cell types causing the observed 
nephrotoxicity? Identification of the expression and function NFATc proteins in the 
proximal tubule will be important for understanding the mechanism of CsA as inhibition 
of calcineurin/NFATc signaling may disrupt transcriptional targets of NFATc proteins 
and may be partially responsible for the nephrotoxicity. 
 
Aims of dissertation 
 The main objective of my thesis research was to study the role of NFATc1 in 
PTCs following an AKI in mice. When I proposed this thesis project, evidence that 
NFATc1 could play a role in maintaining the epithelial phenotype was based on 
unpublished experiments performed in the lab using chimeras and observations of 
NFATc1 expression in the proximal tubule. Chimeric embryos, created by injecting 
Nfatc1-/- cells into WT blastocysts, showed that Nfatc1-/- cells were found at a lower 
frequency in endocardial cells and at a greater frequency in the mesenchyme derived 
cushion suggesting that NFATc1 played a role in maintaining the endothelial phenotype. 
We propose that NFATc1 may have a similar mechanism of maintaining the epithelial 
phenotype of PTCs during the process of kidney injury and repair. We proposed to test 
this hypothesis in the kidney focusing on PTCs because of the observed NFATc1 
expression in the proximal tubule and because CsA has nephrotoxic effects specifically 
affecting the proximal tubule.   
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CHAPTER II 
 
NFATC1+/- MICE HAVE DELAYED RECOVERY FROM AKI 
 
Introduction 
 AKI is an important clinical problem resulting from insults that causes functional 
and structural change in the kidney. The insult leading to AKI can be induced by a toxic 
insult to the nephron following acute or chronic exposure to an environmental and/or 
occupational toxin, from treatment with chemotherapeutic and/or immunosuppressive 
drugs or from an ischemic injury (Basile, 2007). The AKI is marked by changes in the 
serum chemistry and urine with increased concentrations of serum creatinine, BUN, and 
kidney injury molecule 1. Recovery from AKI caused by a nephrotoxic insult requires 
renal tubule cell regeneration. However, the source of the regenerative cells remains 
undefined, as described in Chapter I. 
Taking into account the nephrotoxicity of calcineurin inhibitors and having 
documented expression of NFATc1 in the kidney, we hypothesize that NFATc1 plays a 
role in modifying epithelial regeneration following renal injury. A single dose of HgCl2 
was used to induce AKI in the PTCs of WT mice and mice heterozygous for a null 
mutation in NFATc1 (Nfatc1+/-). Following HgCl2 injury, the Nfatc1+/- mice demonstrated 
increased apoptosis, sustained injury, and delayed regeneration, compared to the WT 
mice. In addition, the Nfatc1+/- mice have decreased expression of NFATc1 mRNA and 
protein throughout the time course compared to WT mice. These data suggest a critical 
role for NFATc1 in regeneration of injured proximal tubule cells. To our knowledge, this 
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is the first example of a phenotype identified in the Nfatc1+/- mouse and suggests a role 
for NFATc1 in the regeneration of injured PTCs.  
 
Methods 
 
Mice 
NFATc1 knock out mice created by excising the Rel DNA binding domain were 
maintained as a heterozygous colony on a pure Balb/c background and genotyped as 
previously described (Ranger et al., 1998a). Primer sequences used to genotype mice are 
listed in Table 2.1. The Institutional Animal Care and Use Committee of Vanderbilt 
University approved all animal studies.  
 
Experimental Protocol 
All experiments were performed on 6-8 week old female littermates. A single 
subcutaneous dose of 8.14 mg/kg HgCl2 (Fisher Scientific) in normal saline causes 
significant AKI in mice on the Balb/c background (Miyaji et al., 2002). Wild type and 
Nfatc1+/- mice were administered HgCl2 and sacrificed 24 hours (1 day), 72 hours (3 
days), 5 days or 10 days later and compared to mice not administered HgCl2, 0 day. WT 
mice analyzed at 0, 1, 3, 5, and 10 days n = 8, 8, 10, 8, and 5, respectively. Nfatc1+/- mice 
analyzed at 0, 1, 3, 5, and 10 days n = 8, 7, 8, 11, and 5, respectively.  See Figure 2.1 for 
schematic diagramming the experimental time course and periods of injury and repair.  
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Table 2.1 Oligonucleotide sequences of primers used to genotype transgenic mice. 
Marker gene Primer sequence     Annealing      Cycles               Fragment 
       Temperature (C˚)                 length (bp) 
 
NFATc1  AGCGTTGGCTACCCGTGATATTGCTGAAGA 68         35  270 WT 
  GTTCCAGGTGACCCAGAAATCAAGGGTCAG    350 KO 
  CTTCCCTGATGTGTGTTGTGGCAGACAAGAT 
 
NFATc1-P2-Cre CCTGGAAAATGCTTCTGTCCG   54         81  105 
  CAGGGTGTTATAAGCAATCCC 
 
NFATc1-P2-LacZ   GCAGCAGGCAGGGTCACAGAGA   58         80  176 
           ACCCCAGGCTGCAAGGAGGATT 
 
R26R  AAAGTCGCTCTGAGTTGTTAT   58         40  500 WT 
  GCGAAGAGTTTGTCCTCAACC      250 KO 
  GGAGCGGGAGAAATGGATATG 
 
R26R-EYFP AAAGTCGCTCTGAGTTGTTAT   58         40  500 WT 
  GCGAAGAGTTTGTCCTCAACC      250 KO 
  GGAGCGGGAGAAATGGATATG  
 
Z/EG  CGGCGGCGGTCACGAACTC   62         30  385  
  TTCAAGGACGACGGCAACTACAAGA 
 
Primer sequences for NFATc1 (Ranger et al, 2000), NFATc1-P2-LacZ (Zhou et al., 2005), sglt2-Cre used to genotype 
NFATc1-P2-Cre (Rubera et al., 2004), and R26R, R26R-YFP (Soriano et al., 1999) have been previously published.  
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Histology 
Dissected kidneys were bisected and fixed in PBS containing 4% 
paraformaldehyde overnight at 4˚, dehydrated in an ethanol gradient and xylene and 
embedded in paraffin. 5 µm sections were cut on a microtome. The AKI score for tubular 
injury was assessed in hematoxylin and eosin stained sections using a semiquantitative 
scale in which ten high power fields (200X) were blinded and scored by Dr. Gilbert 
Moeckel for the percentage of tubules with AKI and assigned a score: 0 = normal; 1 = 
<10%; 2 = 10–25%; 3 = 26–75%; 4 = >75% as previously described (Ramesh and 
Reeves, 2002). Weigert’s Iron Hematoxylin Solution (Sigma) and the Accustain 
Trichrome Stain (Sigma) were used to stain and score interstitial collagen deposits.  
 
Blood serum creatinine concentration 
Blood samples drawn from the orbital vein at each end point were analyzed to 
determine the serum creatinine concentration as previously described (Dunn et al., 2004). 
 
RNA extraction 
A fragment of the outer cortex was snap-frozen and stored at –80˚C.  RNA was 
isolated from 40mg of tissue using the Versagene™ Total RNA Purification Kit and 
DNA contamination was removed using the Versagene ™DNase Treatment Kit. RNA 
quality and concentration was determined using capillary electrophoresis (RNA 6000 
Nano LabChip Kit and Bioanalyzer, Agilent). Samples within each experimental group 
were pooled and single-stranded cDNA was prepared from 10 ug of total RNA using 
oligo dT16 primer and a standard protocol (Transcriptor Reverse Transcriptase, Roche).  
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Quantitative Real-Time PCR (qRT-PCR) 
qRT-PCR was performed in a Light Cycler (Roche). All experiments were done 
using the Light Cycler DNA Master SYBR Green I Kit, 0.5 µM of each primer, 3-5 mM 
MgCl2, and 200 ng cDNA. DNA primer sets (Table 2.2) were designed using different 
exons, when possible, to ensure that the product was from mRNA and not genomic DNA. 
The specificity of the amplified product was evaluated using the melting curve analysis 
and a no template control reaction included in each run. The housekeeping gene, 
GAPDH, was used to normalize the data. The relative change in gene expression was 
determined using the critical threshold (Ct) and the equation Fold Induction = 2-ΔΔCt using 
the wild type 0 Day sample as the calibrator sample and a two-fold increase or decrease 
in expression was considered significant (Livak and Schmittgen, 2001). 
 
Isolation of proximal tubules 
 PTCs were isolated using modification of the methods of Vinay et al. (Vinay et al., 
1981) and as modified in Xu et al. (Xu et al., 2007). Briefly, cortices from HgCl2 treated 
WT or Nfatc1+/- mice were collected and minced in Krebs-Hensleit saline (KHS) buffer 
containing 115 mM NaCl, 24 mM NaHCO3, 10 mM HEPES, 5 mM glucose, 5 mM KCl, 
2 mM NaH2PO4, 1.5 mM MgSO4, 1 mM alanine. The KHS was then enriched with 
0.15% (wt/vol) collagenase type I, 0.5% (wt/vol) bovine serum albumin, and 0.01% 
soybean trypsin inhibitor and incubated at 37˚C for 1 hour to digest the cortices. The 
suspension was strained through a 100-µm sieve, washed and centrifuged at 600 rpm 3 
times. The pellets were combined with 47% Percoll (Amersham) solution mixed with 2X  
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Table 2.2 Oligonucleotides for qRT-PCR analysis of NFATc expression.   
Marker gene Primer sequence     Annealing  Product                  Fragment 
       Temperature (C˚)    Temperature (C˚)   length(bp) 
 
GAPDH  CACTGGCATGGCCTTCCGTG   55           80     253  
       AGGAAATGAGCTTGACAAAG 
 
Nfatc1           GGTGGCCTCGAACCCTATC    55           86     204 
       TCAGTCTTTGCTTCCATCTCCC   
 
Nfatc2            CATCCGCGTGCCCGTGAAAGTC   64           86     430 
           CTGCCCCTGCCCCTGAGAACCA 
 
Nfatc3            GAGCCCATTATGAAACTGAAGGTA  56           83     419 
           AAGTTAGCTGGCTGGAGATAGAGG 
 
Nfatc4            CTTTGGCCCTGACGTGGACTTCTC   62           86     413 
           TAGCCTGGCCCCACCTCATTGTAG 
 
Sequences are listed in the order antisense, sense-primer.  
 45 
KHS and centrifuged at 16,300 rpm for 30 minutes at 4˚C. The lowest band enriched with 
proximal tubule segments was washed with KHS buffer 3 times and utilized for protein 
isolation. 
 
Protein isolation and Western blotting 
 Proximal tubule segments were pelleted and lysed in 25 mM HEPES pH 7.4, 150 
mM NaCl, 5 mM EDTA, 1% Triton X-100, 10% Glycerol, 50 mM NaF (tyrosine 
phosphatase inhibitor), 2 mM NaVO4 (phosphatase inhibitor) and 1% protease cocktail 
inhibitor (Sigma). Concentration was determined by Bradford assay, and 50µg of protein 
was analyzed per lane. NFATc1 was detected by Western blot analysis (mouse 
monoclonal, 7A6, BD Pharmingen). Protein loading was confirmed by Western blot 
analysis for β-actin (mouse monoclonal, Sigma-Aldrich). To quantify the concentration of 
active NFATc1 protein, the dephosphorylated protein band was quantified by 
densitometry (EpiChem; UVP Bioimaging System) and the results were normalized as a 
ratio of NFATc1 to β-actin for each preparation as compared to WT samples at Day 0.  
 
Antibody staining 
PCNA and TUNEL staining were performed on paraffin sections using the PCNA 
Staining Kit (Zymed) and ApopTag ® Apoptosis Detection Kit (Serologicals), 
respectively. 10 high power fields from each mouse were scored blindly for the number 
of PTCs that were TUNEL or PCNA positive.  
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Statistics 
 All data are presented as mean ± SEM. All scoring was performed blinded. Two-
way ANOVA was used to assess the relationship between genotype, and acute kidney 
score, serum creatinine, apoptosis, proliferation, collagen, or NFATc1 mRNA level at 
each time point. Differences between groups were assessed with two-way ANOVA and 
posttest using Bonferroni correction to compare Day 1, 3, 5, and 10 to Day 0 for each 
genotype and to reduce Type I error. A result was considered significant when P<0.05. 
 
Results 
 
Nfatc1+/- mice have sustained AKI 
AKI can be induced by the administration of a single dose of HgCl2 (8.14mg/kg) 
causing a marked injury in the S2 and S3 segments of the proximal tubule in Balb/C mice 
(Hultman and Enestrom, 1986). While Nfatc1-/- null mice die in utero at E13.5 due to 
cardiovascular defects (de la Pompa et al., 1998; Ranger et al., 1998a) and thus 
unavailable for postnatal studies, we induced AKI in WT (Balb/C) (Myers et al.) and 
heterozygous null Nfatc1+/- mice (Ranger et al., 1998a) to determine if genetic attenuation 
of NFATc1 effected the severity of renal injury or the rate of PTC repair. We 
administered HgCl2 to mice and analyzed indices of AKI 1, 3, 5, and 10 days after injury 
compared to day 0 mice that were not treated with HgCl2 (Fig. 2.1 Schematic).  
Compared to the WT mice (Fig. 2.1A), we did not observe any morphological or 
histological differences in the Nfatc1+/- mice before HgCl2 administration (Fig. 2.1F). One 
day after HgCl2 injury, AKI marked by tubular dilation, cellular necrosis, nuclear dropout  
Figure 2.1. Genetic attenuation of NFATc1 causes sustained HgCl2 induced AKI.
Schematic diagramming experimental time course. There was no detectable difference
between WT (A.) and Nfatc1+/- (F.) mice before administration of HgCl2. 1 day after a
single injection of HgCl2 (3mM), AKI, marked by tubular dilatation, nuclear dropout,
and loss of brush borders was observed in both WT (B.) and Nfatc1+/- mice (G.). 3
days after HgCl2 injury, PTCs in WT mice (C.) contained large basophilic nuclei in
the regenerating proximal tubule segment of the nephron. Nfatc1+/- mice (H.) showed
fewer basophilic nuclei suggesting that the PTC remained in an injured state. 5 days
after injury, the WT (D.) mice have basophilic nuclei and fewer injured tubules.
Nfatc1+/- (I.) PTCs have basophilic nuclei 5 days after HgCl2 injury. 10 days after
injury, the injured PTCs of WT (E.) mice have regenerated and have recovered from
the injury as indicated by defined cellular membranes and brush borders. Nfatc1+/- (J.)
mice have disorganized PTC nephron segment. A-J Hematoxylin and eosin stained
sections. Arrow, nuclear dropout; >, proliferating nuclei; +, tubular dilatation;
diamond, disorganization of the PTC nephron segment. 400X Magnification.
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and the loss of defined brush border membranes in PTCs was observed in both WT and 
Nfatc1+/- mice (Fig. 2.1B, G). Three days after HgCl2 injury, PTCs in WT mice (Fig. 
2.1C) contained large basophilic nuclei characteristic of proliferation. Damaged PTCs of 
Nfatc1+/- mice showed fewer basophilic nuclei, suggesting that the proximal tubules 
remained in an injured state (Fig. 2.1H). Five days after injury, PTCs of WT mice (Fig. 
2.1D) show reorganization of the epithelial tubules while the PTCs of Nfatc1+/- mice were 
disorganized or dilated (Fig. 2.1I). Ten days after injury, the injured PTCs of WT mice 
regenerated and recovered from the injury as indicated by defined cellular membranes 
and brush borders (Fig. 2.1E). However, the injury from HgCl2 was sustained at 10 days 
in the Nfatc1+/- as the PTCs nephron segment was not remodeled into a proper tubule and 
was fibrotic (Fig. 2.1J). 
To assess the severity of renal injury, we employed a quantitative evaluation of 
PTC injury defined by the severity of tubular dilation, cellular necrosis, nuclear dropout 
and the loss of defined brush border membranes in PTCs (Fig. 2.2) (Ramesh and Reeves, 
2002). As indicated by the histology in Figure 1, Nfatc1+/- mice had a significant increase 
in AKI throughout the HgCl2 time course compared to WT mice (p<0.0001, Two-way 
ANOVA). Significant AKI was measured in both WT and Nfatc1+/- mice at 1, 3, and 5 
days indicating that the initial response to injury was similar in each group (p<0.001, 
Bonferroni posttest). However, the injury from HgCl2 was sustained in Nfatc1+/- mice and 
significantly higher after 10 days in the Nfatc1+/- mice (p<0.001, Bonferroni posttest) 
while recovery to pre-injury levels occurred in the WT mice by day 10.  
 
Figure 2.2. Nfatc1+/- mice have significant AKI compared to WT. Acute injury scores
to quantify HgCl2 induced injury. Acute injury scores were significantly higher in the
WT and Nfatc1+/- mice after HgCl2 (p<0.0001 WT vs. Nfatc1+/- mice, two-way
ANOVA, ***p<0.001 Bonferroni post test verses day 0). AKI scoring, 0 = normal; 1
= <10%; 2 = 10–25%; 3 = 26–75%; 4 = >75% PTC injury.
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Nfatc1 transcription is decreased in Nfatc1+/- mice 
Expression of NFATc1 is strongly induced through autoregulation of the 
endogenous promoter by transcription factors NFATc1 and NFATc2 (Chuvpilo et al., 
2002a; Zhou et al., 2002). We used quantitative qRT-PCR to measure alterations in 
NFATc1 expression, which was significantly increased in the WT mice throughout the 
time course (p<0.0001, WT vs. Nfatc1+/-, two-way ANOVA) (Fig. 2.3). Before HgCl2 
injury, Nfatc1+/- mice and had a 20% reduction in NFATc1 expression compared to WT 
mice. After HgCl2 injury, Nfatc1 expression was immediately upregulated in the WT 
mice during the initial phase of the injury, Day1. Nfatc1 expression was significantly 
increased in WT mice 3 days after HgCl2 injury correlating with the period of 
regeneration of the PTCs (p<0.001, Bonferroni posttest). However, in Nfatc1+/- mice, 
Nfatc1 expression was attenuated and did not significantly increase throughout the time 
course. Expression of other NFATc transcription factors (Nfatc2, Nfatc3, and Nfatc4) 
were not significantly altered throughout the HgCl2 time course in WT and Nfatc1+/- mice 
(Fig. 2.4) suggesting that other NFATc transcription factors do not compensate for the 
decreased Nfatc1 expression in Nfatc1+/- mice.  This is consistent with previous data 
showing that when the expression of a single NFATc family member is decreased, other 
NFATc proteins are unable to compensate (Wilkins et al., 2002).  
 
NFATc1 protein is upregulated in proximal tubules following HgCl2 injury 
 We were interested in addressing if the amount of NFATc1 protein was 
specifically  decreased in  the proximal tubule segment of Nfatc1+/- mice compared to WT  
Figure 2.3. Nfatc1 expression in the renal cortex is blunted in Nfatc1+/- mice
compared to WT mice following HgCl2 injury. Following treatment with HgCl2, the
WT mice have a significant increase in NFATc1 expression at day 3. (p<0.0001 WT
vs. Nfatc1+/- mice, two-way ANOVA, ***p<0.001 Bonferroni post test verses day 0).
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Figure 2.4. Transcription of other NFATc family members was not altered
following HgCl2 induced AKI. The relative expression of A. Nfatc2, B. Nfatc3, and
C. Nfatc4, in mRNA samples isolated from whole kidney cortex of adult mice.
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mice.  Therefore,  we  repeated  the  HgCl2  time  course  in  WT  and  Nfatc1+/-  mice  
and isolated proximal tubule fractions from 3 individual mice at each time point. The 
purity of the isolated proximal tubule fractions was greater than 95%. Protein extracted 
from the proximal tubule fractions were analyzed by western blot (Fig. 2.5A). We 
observed both phosphorylated and dephosphorylated NFATc1 as the antibody used 
recognizes NFATc1 regardless of phosphorylation status as previously published (Hesser 
et al., 2004; Pan et al., 2007). We quantified the amount of dephosphorylated NFATc1 
protein and normalized the expression to the amount of β-actin detected. Throughout the 
HgCl2 time course, the expression of NFATc1 was significantly increased in the WT 
mice compared to the Nfatc1+/- mice (p = 0.0014, two-way ANOVA, Fig. 2.5B).  Before 
HgCl2 injury, Nfatc1+/- mice had a 10% reduction in NFATc1 expression compared to 
WT mice. The dephosphorylated NFATc1 was significantly increased 3.5-fold in the 
proximal tubules of WT mice 3 days after treatment with HgCl2 (p<0.001, Bonferroni 
posttest) compared to only a 2-fold increase in Nfatc1+/- mice 3 days after treatment 
(p<0.05, Bonferroni posttest vs. Day 0).  
 
NFATc1 attenuation results in increased interstitial collagen following AKI. 
 While interstitial fibrosis is not a characteristic of HgCl2 induced AKI, it is one of 
the hallmarks of CsA induced nephrotoxicity (Burdmann et al., 1994). Therefore, we 
questioned whether, genetic attenuation of NFATc1 might produce a fibrotic response in 
the setting of AKI. After HgCl2 treatment, we observed severe cortical interstitial changes 
and observed more extensive collagen deposition in the kidneys of Nfatc1+/- mice 
compared  to  WT mice  (Fig. 2.6A-B).  We quantified  interstitial  collagen in the  cortex  
Figure 2.5. Dephosphorylated NFATc1 protein is upregulated in proximal tubules
following HgCl2 injury. A. Western blot for NFATc1 and β-actin protein from
isolated proximal tubules. Each lane represents proximal tubule cell lysate from
different mice. Open and closed arrows indicate the dephosphorylated activated and
phosphorylated cytosolic forms of NFATc1, respectively. B. Comparison of
dephosphorylated NFATc1 expression levels normalized to β-Actin in WT and
Nfatc1+/- mice. (p=0.0014 WT vs Nfatc1+/ -mice, two-way ANOVA, ***p<0.001 and *
p<0.05 Bonferroni posttest verses day 0).
A
B
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Figure 2.6. Following treatment with HgCl2, Nfatc1+/- mice have increased
interstitial collagen deposits and disrupted proximal tubule segments. Trichrome
staining 10 days after HgCl2 injury in WT (A.), Nfatc1+/- (B.). C. Quantitative point
counting of interstitial collagen deposits. Nfatc1+/- mice had significantly higher
interstitial collagen 3, 5, and 10 days after HgCl2 injury compared to that seen at Day
0. (**p<0.01 by two-way ANOVA with Bonferroni post test verses day 0)
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using  a  point  counting  assay  (Fig. 2.6C) (Ma et al., 1998).  The interstitial collagen of 
Nfatc1+/- mice was not different compared to WT mice before HgCl2 injury. The 
interstitial collagen in WT mice did not change significantly throughout the time course. 
However, Nfatc1+/- mice had enhanced interstitial collagen deposition 3, 5, and 10 days 
after injury that was not detected before injury (p<0.01, two-way ANOVA, Bonferroni 
posttest).   
 
Treatment with HgCl2 increased serum creatinine 
The nephrotoxicity of HgCl2 was assessed by measuring serum creatinine levels 
in blood samples collected before treatment with HgCl2 (Day 0), and at each end point 1, 
3, 5, and 10 days as described above (Fig. 2.7A). As anticipated, the rise in serum 
creatinine peaked at day 3 following HgCl2 administration consistent with the onset of 
maximal renal damage. There was no difference in serum creatinine concentrations of 
Nfatc1+/- mice compared to WT mice before treatment with HgCl2 suggesting that there 
was no intrinsic renal pathology in the Nfatc1+/- mice prior to HgCl2 administration. 
Similarly, there was no difference in serum creatinine concentrations following HgCl2 
documenting equivalent amounts of injury in both groups.  
 
NFATc1 attenuation results in increased PTC apoptosis 
CsA nephrotoxicity triggers the apoptotic pathway in mitochondria resulting in 
CsA-induced tubular cell toxicity, in vivo and in vitro (Justo et al., 2003). NFATc1 is 
upregulated in activated T cells and can attenuate CsA induced apoptosis in several cell 
types  (Chuvpilo et al., 2002b; Eckstein et al., 2005; Roy et al., 2006).  We hypothesized  
Figure 2.7. Attenuation of NFATc1 causes increased serum creatinine
concentrations, increased apoptosis and decreased PTC proliferation following
HgCl2 injury. A. Serum creatinine concentrations were elevated in WT and Nfatc1+/-
mice following HgCl2 induced AKI. (***p<0.001 Bonferroni post test verses day 0)
B. Apoptosis following HgCl2 induced AKI. 1 and 3 days after HgCl2 injury, there
was a significant increase in the number of apoptotic PTCs in Nfatc1+/- mice. (p=0.043
WT vs Nfatc1+/- mice, two-way ANOVA, ***p<0.001, **p<0.01 and * p<0.05
Bonferroni post test verses day 0) C. Proliferation following HgCl2 induced AKI.
(***p<0.001 Bonferroni posttest verses day 0)
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that NFATc1 protected PTCs from apoptosis associated with AKI. We quantified 
TUNEL stained PTCs in the cortex (Fig. 2.7B). The number of apoptotic PTCs in 
Nfatc1+/- mice was significantly increased throughout the time course compared to WT 
mice (p = 0.043, two-way ANOVA, Fig. 2.7B).  One day after HgCl2 injury, there was a 
significant increase in the number of apoptotic PTCs in WT and Nfatc1+/- mice (p<0.1 
and p<0.001, respectively, Bonferroni posttest). Three days after HgCl2 treatment, the 
number of apoptotic cells remained significantly increased compared to Day 0 in the 
Nfatc1+/- mice (p<0.05, Bonferroni posttest) while the number of apoptotic cells had 
decreased to pretreatment levels by day 3 in Wt mice. These observations were consistent 
with our previous observation of increased injury in Nfatc1+/- mice and suggest that even 
a moderate attenuation of NFATc1 results in increased susceptibility to apoptosis in 
PTCs.  
 
Proliferation is not altered in Nfatc1+/- mice 
 Immunohistochemistry was performed with the proliferation marker proliferating 
cell nuclear antigen (PCNA) and the PCNA+ PTCs were quantified (Fig. 2.7C). Although 
the number of surviving PTCs was decreased in the Nfatc1+/- mice due to apoptosis, 
proliferation was not altered in the Nfatc1+/- mice compared to WT. Thus, while tubular 
regeneration was delayed, the PTC population that escapes apoptosis and survives the 
AKI was able to regenerate the damaged kidney.  
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Discussion 
 NFATc1 was upregulated during the period of regeneration following HgCl2 
induced AKI and modest attenuation of NFATc1 expression through genetic deletion of 
one allele, results in increased apoptosis in PTCs, delayed regeneration, and increased 
fibrosis in response to PTC injury. This is the first direct evidence that NFATc1 has a 
role in maintaining the proximal tubule segment following AKI and to our knowledge, is 
the first example to our knowledge of a phenotype identified in the Nfatc1+/- mice. 
Before HgCl2 administration, we did not observe any morphological or 
histological differences in the Nfatc1+/- mice compared to WT mice. After HgCl2 injury, 
AKI marked by tubular dilation, cellular necrosis, nuclear dropout and the loss of defined 
brush border membranes in PTCs was observed in both WT and Nfatc1+/- mice. 
Throughout the time course of injury, the Nfatc1+/- mice had sustained AKI as seen by 
fewer basophilic nuclei characteristic of proliferation suggesting that the proximal tubules 
remained in an injured state, tubules were disorganized or dilated, and the proximal 
tubule segment was not remodeled into a proper tubule and was fibrotic. Quantification 
of the AKI revealed that the Nfatc1+/- mice had a significant increase in AKI throughout 
the time course.  
 The injury induced by NFATc1 attenuation phenocopies the nephrotoxic injury 
previously associated with CsA. The toxicity and interstitial fibrosis associated with CsA 
is dose independent and it is tempting to speculate that these “side effects” are secondary 
to inhibition of normal NFATc1 activity in the tubule epithelial cells, though this has not 
been proven.  We would speculate that it is critical for the proximal tubule cells to 
regenerate rapidly as delayed regeneration in Nfatc1+/- mice was accompanied by 
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increased interstitial collagen deposition and fibrosis, although interstitial collagen 
deposition was not significantly altered compared to WT.  
 NFATc1 mRNA and protein were significantly decreased in the Nfatc1+/- mice 
during the period of regeneration following HgCl2 mediated AKI. The Real-time PCR 
analysis of renal cortex mRNA shows that NFATc1 was upregulated in WT mice at Days 
3 and 5, during the period of regeneration following HgCl2 induced AKI. Likewise, 
protein isolated from the proximal tubule segment shows that NFATc1 protein expression 
was increased in the proximal tubule at Day 3, during the period of regeneration. The 
decrease in NFATc1 transcription and protein content in the proximal tubule segment of 
Nfatc1+/- mice is due to the genetic deletion of one allele of NFATc1. Decreased NFATc1 
expression from allelic deletion of one allele also was likely to be compounded by an 
attenuation in the autoamplification of NFATc1 from the NFAT dependent inducible 
promoter, a mechanism of transcriptional regulation that is unique to NFATc1, as 
described in Chapter I. These data suggest that a modest attenuation of NFATc1 through 
genetic deletion hinders the course of regeneration.  
 However, while we observed histochemical evidence of progressed AKI in 
Nfatc1+/- mice, we did not observe a significant decrease in the serum creatinine and 
proliferation rates in Nfatc1+/- mice compared to WT. We would question whether further 
attenuation of NFATc1 results in a more severe renal injury marked by increased serum 
creatinine concentrations, sustained AKI, and decreased regeneration of the proximal 
tubule segment. The Nfatc1-/- genotype is lethal and embryos die in utero of 
cardiovascular phenotypes and are thus unavailable for adult studies. Therefore, we 
would propose to use CsA to attenuate all NFATc proteins, as described in Chapter III.   
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CHAPTER III 
 
PHARMACOLOGIC ATTENUATION OF NFATC PROTEINS WITH CSA 
 
Introduction 
Nephrotoxicity is the main adverse effect resulting from the therapeutic use of the 
immunosuppressive drug, CsA. CsA inhibits the phosphatase calcineurin, and prevents 
the dephosphorylation and transcriptional activation of NFATc proteins. The 
nephrotoxicity of CsA is pleiotropic affecting endothelial, epithelial, immune, and 
fibroblast cells (Esposito et al., 2000b). CsA has been shown to be associated with the 
initiation of apoptosis in endothelial and epithelial cells. Acute CsA nephrotoxicity 
causes injury in PTCs characterized by disrupted brush borders, mitochondrial injury, 
vacuolization, and disrupted cytoplasm (Esposito et al., 2000b). Chronic CsA 
nephrotoxicity has been shown to cause PTCs to undergo EMT causing tubular interstitial 
fibrosis in vivo (Iwano and Neilson, 2004; Iwano et al., 2002). In vitro CsA induces PTCs 
to form mesenchymal cells accompanied by increased TGF-β1 and connective tissue 
growth factor proteins (McMorrow et al., 2005). Arteriolar smooth muscle cells are also 
part of the injury spectrum with histology showing apoptosis, or degeneration and 
vacuolization (Blair et al., 1982; Mihatsch et al., 1988). Although several molecules have 
been identified that play a role in this disease process, the mechanism by which CsA 
causes nephrotoxicity is still poorly understood.   
 Heterozygous Nfatc1 mice demonstrate only a moderate reduction in NFATc1 
mRNA and protein as discussed in Chapter II, and homozygous null mice die in utero 
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and are unavailable for post-natal studies. Therefore, we sought to further reduce the 
amount of NFATc1 in the proximal tubules. WT mice were treated daily with 
5mgCsA/kg or10mgCsA/kg prior to and following HgCl2 induced AKI to inhibit 
calcineurin and, therefore, dephosphorylation and activation of all NFATc proteins. 
Serum creatinine concentrations were significantly increased in mice treated with 
10mgCsA/kg following HgCl2 induced AKI and the severity of injury in 10mgCsA/kg 
treated mice was associated with high mortality, as no mice survived longer than 5 days 
after HgCl2 treatment. This work provides additional insights into potential mechanisms 
of CsA induced nephrotoxicity suggesting that NFATc1 is involved in mediating 
regeneration of proximal tubules.  
 
Methods 
 All experiments were performed on inbred 6-8 week old female Balb/c mice. CsA 
was administered daily until each end point. CsA prepared in polyoxyethylated castor oil 
and absolute alcohol (Bedford Labs) was diluted in normal saline and administered in the 
peritoneal cavity at a daily dose of either 5 mg CsA/kg or 10 mg CsA/kg bodyweight. On 
day 8, animals were treated with a single dose of HgCl2 and compared to animals that did 
not receive HgCl2 (n=5 mice/group/time point). A vehicle group was treated with 
polyoxyethylated castor oil and absolute alcohol daily prepared in normal saline 
(n=3/group/time point).  
 
For all other experimental methods see Chapter II.  
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Results 
 
Pharmacologic attenuation of all NFATc proteins with CsA results in severe HgCl2 
induced AKI  
 
Nfatc1-/- null mice die in utero at E13.5 due to cardiovascular defects (de la 
Pompa et al., 1998; Ranger et al., 1998a) and are thus unavailable for postnatal studies. 
The Nfatc1+/- mice demonstrate only a moderate reduction in NFATc1 mRNA and 
protein as described in Chapter II. We sought to further reduce the amount of NFATc1 in 
the proximal tubule. Therefore, we used a pharmacologic approach to attenuate all 
NFATc proteins by treating WT mice daily with CsA. Mice were treated with vehicle or 
CsA daily and we administered HgCl2 to mice after one week of CsA conditioning and 
analyzed indices of AKI 1, 3, 5, and 10 days after injury compared to Day 0 mice that 
were not treated with HgCl2 (Fig. 3.1A). Our initial analysis used a dose of 10 mg 
CsA/kg. The severity of the injury from the combined treatment of 10 mg CsA/kg and 
HgCl2 was evident, as mice did not survive longer than 5 days after HgCl2 injury (Fig. 
3.1B). We repeated the experiments with a reduced dose of 5 mg CsA/kg.  
CsA was administered daily prior to treatment with HgCl2 in order to precondition 
the mice. After 7 days of preconditioning, both 5mgCsA/kg (Fig. 3.2A) and 10mgCsA/kg  
(Fig. 3.2F) treatment groups showed significant vacuolization of the proximal tubule 
compared to controls confirming toxicity of CsA in both treatment groups. One day after 
HgCl2 injury, the histology for WT mice treated with low or high dose of CsA was not 
significantly different. These findings indicate that the initial response to injury was 
similar in each group (Fig. 3.2B,G,K). Three days after injury, the histology of damaged 
PTCs in the  5mgCsA group and  10mgCsA group showed fewer regenerating basophilic  
Figure 3.1. Experimental design and survival of mice treated with CsA and HgCl2.
A. Schematic diagramming experimental time course. B. Kaplan-Meier survival curve
of WT (n = 40), NFATc1+/- (n = 42), 5mgCsA/kg treated mice (n = 27), and 10mgCsA
treated mice (n = 30) following treatment with HgCl2. No deaths occurred in mice
treated with daily with vehicle, 5mgCsA/kg and 10mgCsA/kg without HgCl2 during
the time course (data not shown).
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Figure 3.2. Pharmacologic attenuation of NFATc1 with either low or high doses of
CsA (5mgCsA/kg and 10mgCsA/kg, respectively) causes sustained AKI in mice
following treatment with HgCl2. After daily conditioning with CsA, mice treated with
5mgCsA/kg (A.) and 10mgCsA/kg (F.) showed vacuolization of the PTCs not
observed in the vehicle treated control (data not shown). 1 day after HgCl2 injury,
acute kidney injury is observed in 5mgCsA (B.) and 10mgCsA (G.) treated mice. 3
days after HgCl2 injury, the histology of damaged PTCs of 5mgCsA (C.) and
10mgCsA (H.) treated mice showed no basophilic nuclei suggesting that the proximal
tubules remained in an injured state. 5 days after injury, the PTCs of 5mgCsA (D.)
treated mice have basophilic nuclei, a sign of proliferation. I. 5 days after injury,
kidneys of the 10mgCsA treated mice show tubule casts and severe nephrotoxicity. 10
days after injury, the PTCs of the 5mgCsA (E.) treated mice are severely disorganized.
A-I; Hematoxylin and eosin stained sections. (V, vacuolization; arrow, nuclear
dropout and loss of brush borders; >, proliferating nuclei; +, tubular dilatation;
diamond, disorganization of the PTC nephron segment.) 400X Magnification.
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nuclei than WT and vehicle treated controls suggesting persistent injury in the proximal 
tubules (Fig. 3.2C, H). Five days following HgCl2 administration, PTCs in the 5mgCsA 
group showed evidence of regeneration (Fig. 3.2D). However, 5 days after injury, all 
PTCs of 10mgCsA mice are injured, without evidence of regeneration (Fig. 3.2I). In the 
5mgCsA Group, the injury from HgCl2 was sustained at 10 days compared to WT mice 
and was accompanied by disorganization of the PTCs nephron segment (Fig. 3.2E). 
As indicated by the histology in Figure 3.2, 5mgCsA/kg and 10mgCsA/kg treated 
mice had a pronounced AKI throughout the HgCl2 time course compared to WT mice 
(p=0.0063 WT vs. 5mgCsA/kg and p<0.0001 WT vs. 10mgCsA/kg compared by two-
way ANOVA, Fig. 3.3). After HgCl2 injury, significant AKI was measured in both 
5mgCsA/kg and 10mgCsA/kg treated mice indicating that the initial response to injury 
was similar in each group at days 1, 3, and 5 (p<0.001, Bonferroni posttest). The 
5mgCsA/kg treated mice had sustained AKI at day 10 similar to the Nfatc1+/- mice 
(p<0.001, Bonferroni posttest).  
 
Nfatc1 transcription is repressed in CsA treated mice 
 Because NFATc1 expression can be modulated via an autoregulation at the 
transcriptional level, we used qRT-PCR to measure the expression of Nfatc1 in the 
kidney following daily treatments with CsA. Compared to WT mice, the expression of 
Nfatc1 was significantly reduced in mice treated with 5mgCsA/kg and 10mgCsA/kg 
(p=0.0045 WT vs. 5mgCsA/kg and p<0.0001  WT  vs.  10mgCsA/kg  compared  by  two- 
way ANOVA). The 5mgCsA group had a 20% reduction in Nfatc1 expression, similar to 
Nfatc1+/- mice and the  10mgCsA group had a  40% reduction in Nfatc1 expression before  
Figure 3.3. Quantification of HgCl2 induced acute kidney injury. Acute kidney
injury scores are significantly increased in mice treated with CsA following HgCl2
induced injury (p=0.0063 WT vs. 5mgCsA/kg treated mice and p<0.0001 WT vs
10mgCsA/kg treated mice, two-way ANOVA; ***p<0.001 Bonferroni posttest
compared to Day 0). Acute kidney injury score 0 = normal; 1 = <10%; 2 = 10–25%; 3
= 26–75%; 4 = >75% of PTC are injured showing loss of brush borders, dilated
tubules, or nuclear dropout.
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HgCl2 injury compared to WT mice (Fig. 3.4). Nfatc1 expression remained suppressed 
and did not significantly increase in 5mgCsA/kg treated mice until 5 days after HgCl2 
injury, similar to the Nfatc1+/- mice (p<0.001, Bonferroni posttest vs. day 0).  
 Treatment with the high dose of CsA showed that Nfatc1 expression remained 
significantly reduced after HgCl2 injury in 10mgCsA group. Nfatc1 expression was not 
significantly altered in groups of mice treated with vehicle, 5mgCsA/kg or 10mgCsA/kg 
without HgCl2 throughout the duration of the time course.  The transcription of other 
NFATc proteins Nfatc2, Nfatc3, and Nfatc4, was analyzed by qRT-PCR (Fig. 3.5A-C). 
The expression of Nfatc3 and Nfatc4 were decreased in response to CsA treatment and 
there was not a significant change in their expression throughout the HgCl2 time course. 
However, the expression Nfatc2 was significantly increased at day 5 in 5mgCsA/kg 
treated compared to expression at day 0 (p<0.001, Bonferroni posttest compared to  
5mgCsA/kg  at day 0) and the transcription of Nfatc2 in 5mgCsA/kg treated mice was 
significantly increased compared to WT (p=0.0117, WT vs. 5mgCsA/kg compared by 
two-way ANOVA). 
 
Combined treatment with HgCl2 and CsA causes severe mitochondrial injury 
 CsA has been shown to cause tubular cell apoptosis resulting from mitochondrial 
injury and treatment with HgCl2 has been shown to form giant mitochondria or 
mitochondria with flocculent matrix deposits within tubular epithelia (Justo et al., 2003; 
McDowell et al., 1976).  We  therefore  performed  ultrastructure analysis on mice treated  
with both 5mgCsA and HgCl2 and examined the mitochondria of tubular epithelial cells 
(Fig. 3.6).  One day after treatment with HgCl2, the mitochondria appeared normal and do  
Figure 3.4. Nfatc1 transcription is decreased in the cortex following HgCl2 injury.
The relative expression of Nfatc1 in RNA isolated from the cortex shows blunted
NFATc1 expression in CsA treated mice (p=0.0045 WT vs. 5mgCsA/kg treated mice
and p<0.0001 WT vs. 10mgCsA/kg treated mice, two-way ANOVA; *** p<0.001
Bonferroni posttest compared to Day 0)
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Figure 3.5. Transcription of other NFATc family members was not altered
following HgCl2 induced acute kidney injury. The relative expression of A. Nfatc2,
B. Nfatc3, and C. Nfatc4, in mRNA samples isolated from whole kidney cortex of
adult mice.
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Figure 3.6. Prolonged exposure to 5mgCsA/kg after HgCl2 induced AKI causes
severe mitochondrial injury characterized by vacuolization and disrupted cristae. A.
1 after HgCl2 injury. B. 10 days after HgCl2 injury. Bar represents 1µm. (V, vacuole;
arrow, disrupted cristae)
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not have the flocculent matrix deposits as previously reported in rats 24 hours after HgCl2 
injury (McDowell et al., 1976). However, 10 days after treatment with HgCl2, the 
mitochondria contained large vacuoles and showed disorganized cristae. The combined 
treatment of CsA and exposure to HgCl2 causes a severe injury that is greater than 
exposure to CsA or HgCl2 alone.  
 
NFATc1 attenuation results in increased interstitial collagen following AKI. 
 Interstitial fibrosis is one of the hallmarks of CsA induced nephrotoxicity. After 
HgCl2 treatment, we observed severe cortical interstitial changes and observed more 
extensive collagen deposition in the kidneys of mice treated with low and high doses of 
CsA compared to WT mice (Fig. 3.7A,B), as described in Chapter II. We quantified 
interstitial collagen in the cortex using a point counting assay (Fig. 3.7C) (Ma et al., 
1998).  There  was no significant difference in interstitial collagen between the groups of  
mice treated with vehicle, 5mgCsA/kg, or 10mgCsA/kg before treatment with HgCl2. 
Following HgCl2 injury, mice treated with 10mgCsA/kg had significantly higher 
interstitial collagen compared to WT mice (p=0.0013 WT vs. 10mgCsA/kg compared by 
two-way ANOVA). Mice treated with vehicle, 5mgCsA/kg, or 10mgCsA/kg without 
HgCl2 did not have a significant change in interstitial collagen deposits throughout the 
time course. 
 
 
Figure 3.7. Following treatment with HgCl2, mice with attenuated NFATc
expression have increased interstitial collagen deposits and disrupted proximal
tubule segments. Trichrome staining 10 days after HgCl2 injury in 5mgCsA/kg treated
mice (A.) and 10mgCsA/kg treated mice (B.). C. Quantitative point counting of
interstitial collagen deposits show that 10mgCsA/kg treated mice have significantly
increased interstitial collagen (p=0.0013 WT vs. 10mgCsA/kg treated mice, two-way
ANOVA; *p<0.05, **p<0.01 by two-way ANOVA with Bonferroni posttest verses
day 0.
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Pharmacologic attenuation of all NFATc proteins with CsA results in increased serum 
creatinine concentrations  
 
 The nephrotoxicity of HgCl2 and CsA was assessed by measuring serum 
creatinine levels in blood samples collected before daily treatment with CsA, before 
treatment with HgCl2 (Day 0), and at 1, 3, 5, and 10 days as described above (Fig. 3.8A). 
Daily treatment with either low or high dose of CsA for one week did not increase serum 
creatinine concentrations over starting concentrations (data not shown). Serum creatinine 
concentrations were significantly increased in mice treated with 10mgCsA/kg following 
HgCl2 induced AKI (Fig. 3.8A, p<0.0001 comparing WT vs. 10mgCsA/kg treated mice 
by two-way ANOVA). The severity of injury in the 10mgCsA/kg treated mice was 
associated with high mortality and mice did not survive longer than 5 days after HgCl2 
treatment. The high serum creatinine concentrations recorded for mice treated with both 
10mgCsA/kg and HgCl2 suggest that the high mortality rate within this group was 
associated with chronic renal failure. Notably, mice treated with vehicle, 5mgCsA/kg, or 
10mgCsA/kg and were not exposed to HgCl2 showed no significant change in serum 
creatinine concentrations throughout the time course. 
 
NFATc1 attenuation results in increased PTC apoptosis 
 The mechanism of CsA nephrotoxicity has been shown to trigger the apoptotic 
pathway in mitochondria resulting in CsA-induced tubular cell toxicity, in vivo and in 
vitro (Justo et al., 2003). We hypothesized that NFATc1 protected epithelia from 
apoptosis associated with AKI as NFATc1 has been shown to be upregulated in T cells in 
order  to  prevent  CsA  induced  apoptosis  (Chuvpilo et al., 2002b; Eckstein et al., 2005; 
Roy et al., 2006). We therefore quantified TUNEL stained PTCS in the cortex. Mice  
Figure 3.8. Attenuation of NFATc with CsA increased serum creatinine
concentrations, increased apoptosis and decreased PTC proliferation following
HgCl2 injury. A. Serum creatinine concentrations are significantly increased in mice
treated with CsA and HgCl2 (p<0.0001 WT vs. 10mgCsA/kg treated mice, two-way
ANOVA). B. Apoptosis is significant increased in PTCs in mice treated with CsA and
HgCl2 (p=0.0063 WT vs. 5mgCsA/kg and p<0.0001 WT vs. 10mgCsA/kg treated
mice, two-way ANOVA). C. Proliferation is significantly decreased in mice treated
with 10mgCsA/kg following HgCl2 induced AKI compared to WT mice (p=0.0013
WT vs. 10mgCsA/kg treated mice, two-way ANOVA). A-C, *p<0.05, **p<0.01,
***p<0.001 by two-way ANOVA with Bonferroni posttest verses day 0.
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treated with vehicle,  5mgCsA/kg,  or  10mgCsA/kg  without  HgCl2  do  not  have  a  
significant change in apoptosis throughout the time course. (Fig. 3.8B). The number of 
apoptotic PTCs was significantly increased in mice treated with 5mgCsA/kg and 
10mgCsA/kg (Fig. 3.8B, p=0.0063 and p<0.0001 comparing WT vs. 5mgCsA/kg and 
WT vs. 10mgCsA/kg, respectively, by two-way ANOVA). These data indicate that PTCs 
with uninhibited NFATc1 expression or activation are protected from extensive 
apoptosis.  
 
Proliferation is inhibited in CsA treated mice 
 CsA has been shown to reduce cell proliferation (Roy et al., 2006). 
Immunohistochemistry performed with the proliferation marker PCNA showed that there 
was not a difference in the amount of proliferating PTCs in the 5mgCsA/kg and 
10mgCsA/kg treated mice prior to HgCl2 injury (Fig. 3.8C) compared to WT (Fig. 2.7D). 
Mice treated with 10mgCsA/kg had significantly decreased PTC proliferation following 
HgCl2 induced AKI compared to WT mice (Fig. 3.8C, p=0.0013 comparing WT vs. 
10mgCsA/kg treated mice by two-way ANOVA). Proliferating PTCs were identified in 
the 5mgCsA/kg treated mice 3 days after HgCl2 injury with the peak in proliferation at 
day 5. However, the group of mice treated with 10mgCsA/kg had fewer proliferating 
PTCs at day 5 compared to WT. There were not significant changes in PTC proliferation 
in mice treated daily with vehicle, 5mgCsA/kg, or 10mgCsA/kg for the duration of the 
time course without HgCl2.  
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Discussion 
 The data presented in this chapter show that WT mice treated with moderately 
low and high doses of CsA, to pharmacologically inhibit calcineurin and all members of 
the NFATc family, have lowered Nfatc1 expression in the kidney and when exposed to 
HgCl2 the regenerative capacity of PTCs is impaired ultimately resulting in renal failure 
and death. One of the most unexpected results of these studies was the dramatic renal 
injury that occurred following HgCl2 administration in mice receiving 10mgCsA/kg. 
Andoh et al. administered 100mgCsA/kg, a 10-fold higher dose and reported that this 
high dose did not alter structure or function in mice on a low-sodium diet (Andoh et al., 
1997). However, in our analysis, 10mgCsA/kg resulted in increased PTC apoptosis, 
decreased proliferation, renal failure and death in all mice following HgCl2 induced AKI. 
Thus, CsA, even at low doses not associated with chronic changes may result in an 
increased vulnerability to renal insult resulting in AKI that has not been previously 
appreciated. We would hypothesize that attenuation of NFATc1 using CsA reduces the 
number of PTCs due to increased and sustained apoptosis thereby reducing the number of 
PTCs available to proliferate and regenerate the damaged PTC segment following 
exposure to a second nephrotoxin.  
 The toxicity and interstitial fibrosis associated with therapeutic clinical CsA usage 
is dose independent and it is tempting to speculate that these “side effects” are secondary 
to inhibition of normal NFATc1 activity in the tubule epithelial cells, although this has 
not been proven. We would reason that it is critical for the proximal tubule cells to be 
able to regenerate rapidly as delayed regeneration in 5mgCsA/kg and 10mgCsA/kg 
treated mice was accompanied by increased interstitial collagen deposition and fibrosis.  
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 Although CsA is pleiotropic and our use of CsA does not reduce NFATc1 in the 
proximal tubule specifically, it is tempting to speculate that some of the nephrotoxicity 
associated with clinical use of CsA may result from NFATc1 inhibition and provides an 
exciting mechanism for future analysis. 
 Our analysis of the effects of combined treatment with CsA and HgCl2 induced 
AKI was performed first using the high dose of CsA. After inducing such a high 
mortality rate, recording high serum creatinine concentrations, and observing severe 
pathologic damage, we repeated the experiment with the low dose of CsA. Because the 
experiments were performed in this order, we did not have the foresight to prepare 
samples from mice treated with the high dose of CsA for electron microscopy and do not 
feel that it would be ethical to repeat treatment with such a high dose. Therefore, we can 
only speculate that EM performed on such samples would show a more severe 
mitochondrial injury defined by large vacuoles and disorganized cristae than the injury 
observed in Figure 3.6. As presented here, combined treatment with low does of CsA and 
HgCl2 caused severe mitochondrial injury as the mitochondria contained large vacuoles 
and showed disorganized cristae. Previously published work has shown that CsA cause 
tubular cell apoptosis resulting from mitochondrial injury and treatment with HgCl2 alters 
the structural integrity of the mitochondria, as described above (Justo et al., 2003; 
McDowell et al., 1976).  
 However, Whole kidney cortex samples from each mouse were frozen at time of 
death to be used to extract RNA and protein. qRT-PCR to analyze changes in NFATc1 
transcription confirmed that treatment with both low and high doses of CsA significantly 
reduced Nfatc1 transcription compared to WT mice. We observed a decrease in 
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transcription of NFATc3 and NFATc4 and increase in NFATc2 transcription in mice 
treated with 5mgCsA/kg, 5 days after injury. Although NFATc proteins are expressed in 
cortical tubules during development and in the adult, the expression profile of NFATc2 
has not been identified in the adult kidney. Therefore, it is tempting to speculate that 
NFATc2 may play a role in proximal regeneration as NFATc2 has been shown to play a 
role in the autoamplification of NFATc1 (Zhou et al., 2002). However, further 
experiments are required to confirm this mechanism.  
 The western blots performed using protein samples isolated from the cortex were 
unsuccessful in identifying NFATc1. We determined that it was unnecessary to repeat 
these costly experiments in order to measure the decrease in NFATc1 protein expression 
specifically in the PTCs of mice treated with CsA when we recorded decreased Nfatc1 
mRNA expression. CsA inhibits calcineurin thus preventing the dephosphorylation and 
transcriptional activation of NFATc proteins. Therefore, we would expect to observe a 
decrease in the amount of dephosphorylated NFATc1 protein similar to Nfatc1+/- mice in 
mice treated with 5mgCsA/kg and a further reduction of NFATc1 protein and possibly no 
dephosphorylated NFATc1 protein in mice treated with 10mgCsA/kg. The data presented 
here confer that combined treatment of CsA and exposure to HgCl2 causes nephrotoxicity 
that is more severe than exposure to CsA or HgCl2 alone.  
 In conclusion, we have described the significant renal damage that results from 
the coadministration of CsA and HgCl2. NFATc protein expression was attenuated 
pharmacologically with moderately low doses of CsA, in mice. Taking into account the 
clinical nephrotoxicity of calcineurin inhibitors and significant renal injury recorded in 
mice treated with HgCl2 and CsA, we would hypothesize that NFATc1 plays a role in 
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modifying epithelial regeneration following renal injury and propose a possible two hit 
hypothesis as a mechanism to explain CsA induced nephrotoxicity.  
 These findings are significant, as this is the first study to report that 
coadministration of CsA and HgCl2 induces a severe renal injury in vivo. While the 
nephrotoxicity associated with CsA is pleiotropic and the PTCs are only one cell 
population injured, our data would suggest that in addition to adverse vascular effects, 
CsA also renders the proximal tubule especially susceptible to toxic injuries from 
exposure to additional nephrotoxins resulting in heightened injury and provides 
additional insights into the pathology of immunosuppressive nephropathy. This two-hit 
hypothesis may provide a mechanism for CsA induced nephrotoxicity. However, we do 
not know what the transcriptional targets of NFATc1 are in the proximal tubule segment, 
as this is the first report of a role for NFATc1 in the proximal tubule. It is tempting to 
speculate that NFATc1 targets proteins that maintain the epithelial phenotype of the 
proximal tubule segment and proteins that control the rate of proliferation and 
regeneration of this segment following a renal injury. Furthermore, administration of CsA 
following a transplantation to inhibit the immune system and prevent rejection of the 
grafted tissue or transplanted organ inhibits the dephosphorylation and transcriptional 
activation of NFATc1 thus preventing the regenerative response of NFATc1 target 
proteins. Experiments not performed in this thesis are required to address these questions.  
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CHAPTER IV 
 
ACCENTUATED EXPRESSION OF NFATC1 IDENTIFIES A PROGENITOR 
PROXIMAL TUBULE EPITHELIAL CELL POPULATION 
 
 
Introduction 
  Recovery from AKI caused by a nephrotoxic insult requires renal tubule cell 
regeneration. Several investigators have attempted to identify a cell population capable of 
repairing tubular damage and have focused on identifying a progenitor cell population 
that is a circulating population originating from bone marrow, an adjacent cell population 
that undergo EMT or transdifferentiation, or a resident PTC. Taking into account the 
nephrotoxicity of calcineurin inhibitors and having documented expression of NFATc1 in 
the kidney, we propose that NFATc1 plays a role in modifying epithelial regeneration 
following renal injury.  
 We wanted to identify NFATc1 expression in the proximal tubule segment over 
the course of injury and repair. To accomplish this, we turned to use NFATc1 transgenic 
lines that express LacZ [NFATc1-P2-LacZ (Zhou et al., 2005)] under the control of an 
NFATc1 enhancer domain important for autoamplification of NFATc1. We demonstrated 
accentuated NFATc1 expression in a subpopulation of proximal tubule cells following 
HgCl2 injury. This subpopulation did not undergo apoptosis following HgCl2 injury and 
cells expressing the reporter colocalized with a proliferation marker. We questioned if 
this subpopulation of cells had regenerative potential and performed lineage analysis 
using a novel transgenic mouse line that expresses Cre recombinase (NFATc1-P2-Cre) 
under the control of the NFATc1 enhancer domain. We documented that the NFATc1 
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labeled PTCs are resistant to apoptosis and subsequently proliferate to repair the damaged 
proximal tubule segment. These data provide evidence that suggest a self-renewing 
resident progenitor population of PTCs and further supports a critical role for NFATc1 in 
regeneration of injured.  
 
Methods 
 
Transgenic mice 
NFATc1-P2-LacZ mice have been previously described [BB-HSP-LacZ (Zhou et 
al., 2005)]. NFATc1-P2-Cre transgenic mice contain the minimal NFATc1-P1 promoter 
(Zhou et al., 2002), a Cre recombinase cassette, and the NFATc1 enhancer domain (see 
below, Fig. 4.1). NFATc1-P2-LacZ, NFATc1-P2-Cre, and R26R mice are maintained on 
the B6D2F1 background and were genotyped using primers listed in Table 2.1.  
 
Experimental Protocol. 
All experiments were performed on 6-8 week old female mice using a single 
subcutaneous dose of 8.14 mg/kg HgCl2 in normal saline to induce significant AKI. 
NFATc1-P2-LacZ n = 3 for each time point. For lineage tracing, a single bolus of BrdU 
(GE Healthcare) was administered to NFATc1-P2-Cre;R26R mice followed by a 2 hour 
(Day 0, Day 1, Day 3 and Day 5) or 5 day (Day 10) chase, n = 3 for each time point. 
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Histology. 
Dissected kidneys were bisected and fixed in PBS containing 4% 
paraformaldehyde overnight at 4˚C, dehydrated in an ethanol and xylene gradient and 
embedded in paraffin. 5 µm sections were cut on a microtome.  
 
β-Galactosidase detection 
Kidneys were bisected, fixed in PBS containing 0.2% glutaraldehyde, 5 mM 
EGTA, 100 mM MgCl2 for 4 hours at room temperature with a solution change after 2 
hours, and cryoprotected in PBS containing 15%- and 30% sucrose before embedding in 
OCT (Ma et al., 2002). 10 µm sections were cut, dried at room temperature for 30 
minutes, washed in a PBS detergent containing 2 mM MgCl2, 0.01% Na-deoxycholate, 
and 0.02% NP40, stained in X-Gal solution, pH 7.50, and post-fixed in 4% 
paraformaldehyde, counterstained with eosin or nuclear fast red, and mounted in 
Permount (Fisher).   
 
Antibody staining 
Immunofluorescence with the anti-β-Gal antibody (Dr. Lim, University of 
Michigan) and anti-cleaved caspase 3 (Cell Signaling) were detected on adjacent 10 µm 
cryosections with TRITC and FITC labeled goat anti-rabbit antibodies (Jackson), 
respectively, nuclei stained using Hoechst Dye 33342 (Molecular Probes), and mounted 
in Vectashield Mounting Media (Vector). Anti-E-Cadherin (BD Biosciences) and anti-β-
Gal antibody immunofluorescence was performed on paraffin sections 
Immunohistochemistry with X-Gal and biotinylated lotus tetragonolobus lectin (LTL, 
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Vector) were detected on 10µm cryosections. BrdU labeled PTC nuclei were identified 
using the anti-BrdU antibody (Abcam) and biotinylated-LTL on X-Gal stained slides to 
score the NFATc1-P2-Cre expression pattern.  
 
Statistics 
 All data are presented as mean ± SEM. All scoring was performed blinded. 
Differences between groups were assessed with two-way ANOVA and posttest using 
Bonferroni correction to compare Day 1, 3, 5, and 10 to Day 0 for each genotype and to 
reduce Type I error. A result was considered to be significant when P<0.05. 
 
Results 
 
Transgenic NFATc1-P2-LacZ reporter expression documents that NFATc1 is 
upregulated in a subpopulation of PTCs 
 
 Our lab developed a transgenic strain of mice, NFATc1-P2-LacZ (Fig. 4.1A), 
containing an enhancer element located within the first intron of NFATc1 that expresses 
nuclear localized β-Gal in a subset of endocardium of the developing mouse heart 
recapitulating endogenous NFATc1 expression during development (Zhou et al., 2005). 
This  P2 enhancer  element plays  an important  role in  controlling  auto-amplification  of  
NFATc1 (Zhou et al., 2002; Zhou et al., 2005). We used NFATc1-P2-LacZ mice to 
delineate NFATc1 activation in the adult kidney and observed expression in smooth 
muscle cells of large renal arteries, but no expression in glomerular, interstitial, or tubular 
cell populations (Fig. 4.1B). We repeated the HgCl2 dosage and time course as described 
above  using  this  NFATc1-P2-LacZ  transgenic line.  LacZ expression is activated 1 day  
Figure 4.1. The NFATc1-P2-LacZ reporter is activated and expressed in the outer
cortex after HgCl2 induced AKI. The HgCl2 time course was repeated in NFATc1-P2-
LacZ mice. A. Schematic of the NFATc1-P2-LacZ transgenic construct. B. Before
treatment with HgCl2, the NFATc1-P2-LacZ reporter is not active in any tubule
epithelial, glomerular, or interstitial cell populations. Following HgCl2 injury, the
NFATc1-P2-LacZ reporter is expressed in cortical tubules at day 1 as seen by the
nuclear localized X-Gal stain (C.). The NFATc1-P2-LacZ expression expands on day
3 (D.) and expression is decreased by day 5 (E.). B-E X-Gal staining with nuclear fast
red counterstain. Magnification, 100X.
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after HgCl2 injury as seen with X-Gal staining (Fig. 4.1C). The number of cells 
expressing LacZ increases at Day 3 (Fig. 4.1D) and subsequently decreases at Day 5 (Fig. 
4.1E). By day 10, the number of LacZ positive PTCs is greatly reduced (data not shown), 
a trend analogous to the Real-time PCR expression analysis of NFATc1 described above 
(Fig. 2.3).  
Expression of the NFATc1-P2-LacZ reporter after HgCl2 was not observed in any 
glomerular or interstitial cell type. The expression was apparent in tubular epithelial cells 
in the outer cortex and minimal expression in the inner cortex. We performed dual label 
immunohistochemistry with tubular segmental markers to further delineate the specific 
cellular identity of NFATc1 expressing cells. Immunofluorescence performed with anti-
β-Gal and the proximal tubule specific marker Lotus tetragonolobus lectin (LTL, Fig. 
4.2A) show that activation of LacZ is in the proximal tubule segment. Furthermore, 
activation of LacZ was specific to a subset of PTCs as all proximal tubules were not 
labeled with β-Gal. NFATc1-P2-LacZ was not expressed in any distal tubule or 
collecting duct as seen by immunofluorescence with anti-E-cadherin (Fig. 4.2B). E-
cadherin has been previously shown to be expressed differentially on the basal and lateral 
membranes of distal tubules, collecting ducts, and in the medulla with very weak 
expression in the proximal tubule (Prozialeck et al., 2004).  
We were intrigued that the expression of the NFATc1-P2-LacZ reporter was 
detected in only a subset of PTCs. To further characterize this subpopulation, 
immunofluorescence was performed   on adjacent   sections with β-Gal and   Cleaved 
Caspase 3 antibodies and showed that NFATc1-P2-LacZ expression in PTCs did not 
colocalize with apoptotic PTCs (Fig. 4.2C). This is consistent with TUNEL quantification  
Figure 4.2. NFATc1-P2-LacZ is expressed in a subset of proximal tubules that
escape apoptosis after HgCl2 induced AKI. A. Immunohistochemistry performed
using anti-B-Gal antibody and proximal tubule specific marker, lotus tetragonolobus
lectin reveals that the NFATc1-P2-LaZ reporter is expressed specifically in the
proximal tubule segment of the nephron in a subset population of PTCs.
Representative image from Day 3. B. E-cadherin is expressed in distal tubules and
collecting duct and does not colocalize with the majority of NFATc1-P2-LacZ
expression after HgCl2. C. Immunofluorescence performed with β-Gal (red) and
cleaved caspase 3  antibodies show 3 days after injury, the NFATc1-P2-LacZ PTCs
are not apoptotic. H. Immunofluorescence performed with β-Gal and cleaved caspase
3 antibodies before HgCl2 injury. F. Hematoxylin stained nuclei. G + H. DAPI stained
nuclei (blue). Magnification. 200X.
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performed previously (Fig. 2.7). In addition, immunofluorescence with anti-
phosphorylated histone-H3 (pHH3), a marker of the S-phase, showed that although only a 
few cells were in S-phase and labeled with pHH3, the expression colocalized with anti-β-
Gal positive PTCs suggesting that these cells proliferate to regenerate the damaged 
proximal tubule segment (Fig. 4.2D).  These data suggest that the P2 locus, which reports 
NFATc1 autoamplification, is activated in and identifies a subpopulation of PTCs that are 
resistant to apoptosis following AKI and this subpopulation subsequently undergoes 
proliferation. 
Because the NFATc1-P2-LacZ transgenic construct contains the minimal HSP 
promoter, we were concerned that the LacZ reporter was being activated by HSP activity 
following HgCl2 injury and not exclusively by the NFATc1-P2 enhancer element. To 
confirm that the NFATc1-P2 enhancer element was responsible for the activation of the 
LacZ reporter, LLC-PK1 cells, a porcine proximal tubule epithelial cell line, were 
transfected with NFATc1-P2-LacZ (containing the minimal HSP promoter) and an HSP-
LacZ plasmid. Cells transfected with NFATc1-P2-LacZ had a significant 3-fold increase 
in X-Gal staining cells following treatment with HgCl2 compared to LLC-PK1 cells 
transfected HSP-LacZ (Fig. 4.3, p=0.001, Mann-Whitney U test). 
 
The NFATc1-P2-Cre reporter identifies a progenitor subpopulation of PTCs 
 We questioned whether the apoptotic resistant population of PTCs marked by the 
NFATc1-P2 enhancer domain contributed to regeneration of the PTCs. To investigate 
this possibility, NFATc1-P2-Cre mice (Fig. 4.4A), a transgenic strain that utilizes the 
NFATc1-P2  enhancer  element to drive  Cre  recombinase  expression,  were  crossed  to  
Figure 4.3. NFATc1-P2-LacZ is activated in LLC-PK1 cells following treatment
with HgCl2, in vitro. LLC-PK1 cells, a porcine proximal tubule cell line, transfected
with NFATc1-P2-LacZ have a significant increase in X-Gal labeled cells compared to
cells transfected with control plasmid, HSP-LacZ. (*** p=0.001, Mann-Whitney U)
***
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Figure 4.4. Lineage analysis using the NFATc1-P2-Cre reporter marks a progenitor
subpopulation of PTCs that regenerate PTCs. A. Schematic of the NFATc1-P2-Cre
transgenic construct. B. Before HgCl2 treatment, NFATc1-P2-Cre is not expressed in
any tubule epithelial, glomerular, or interstitial cell population, confirming that the
reporter construct was not activated previously during development. C. Following
HgCl2 injury, the NFATc1-P2-Cre reporter is activated and expressed in PTCs cells at
day 5 and the number of X-Gal positive cells increases by day 10 (D.). E-F. Staining
of serial sections with Xgal (E.) and LTL (F.). Red arrows reference proximal tubule
segments on adjacent sections. G. Costaining 5 days after HgCl2 injury shows
colocalization of the NFATc1-P2-Cre (blue, X-Gal staining of R26R reporter) and
BrdU-labeled (brown, arrows) PTC identifying a subset population of PTCs that
proliferate after injury. H. Quantification of PTCs cells that are positive for X-Gal,
BrdU, or both X-Gal and BrdU reveal that at Day 3 there were an equal number of X-
Gal+/BrdU+ and X-Gal-/BrdU+ population each composing approximately 5% of the
PTC counted cells. At day 10, 27% of the PTCs are NFATc1-P2-Cre derivatives. B-E,
Nuclear fast red counterstain. Magnification, B-D. 100X; E. 400X.
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R26R reporter mice (Soriano, 1999). This lineage analysis approach allowed us to 
genetically identify most, if not all, PTCs in which NFATc1-P2 was activated as well as 
their progeny. We repeated the HgCl2 time course as described above with NFATc1-P2-
Cre mice.  Prior to treatment with HgCl2, LacZ was not expressed in any tubular, 
glomerular, or interstitial cells confirming that as previously documented by the 
NFATc1-P2-LacZ transgenic line, the P2 promoter element was not activated during 
renal development (Fig. 4.4B). As with the NFATc1-P2-LacZ mice, treatment with 
HgCl2 activated the Cre reporter and cytoplasmic β-Gal was observed at day 5 (Fig. 
4.4C).  Interestingly, in contrast to previous experiments with the NFATc1-P2-LacZ 
where the number of LacZ positive cells decreased 5 days after HgCl2 treatment 
indicating decreased NFATc1 expression, the number of X-Gal stained PTCs in 
NFATc1-P2-Cre mice increased by day 10 (Fig. 4.4D). Immunolabeling of serial sections 
with X-Gal and LTL confirms that NFATc1-P2-Cre expression was specific to the PTC 
population (Fig. 4.4E-F). Because or experiments with NFATc1-P2-LacZ mice 
documented an attenuation of NFATc1 expression by day 5, we conclude that the 
increased number of positive PTCs in the cortex of NFATc1-P2-Cre mice after 10 days 
represents the clonal expansion of the PTCs in which NFATc1 was originally expressed. 
 To quantify the regenerative potential of NFATc1-P2-Cre expressing PTCs, we 
stained sections with X-Gal and performed dual-labeling immunohistochemistry with the 
anti-BrdU antibody and quantified X-Gal-BrdU-, X-Gal-BrdU+, X-Gal+ BrdU+, X-Gal+ 
BrdU-PTCs (Fig. 4.4G-H). Before treatment with HgCl2, 0.32% of the PTCs were X-Gal-
BrdU+ and 0.03% of PTCs were X-Gal+ BrdU-. 3 days after HgCl2 injury there was not a 
significant difference in the number of X-Gal-BrdU+ and X-Gal+ BrdU+ cells. However, 5 
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days after HgCl2 injury, the number of X-Gal+ BrdU+ PTCs was 2.5-fold greater than X-
Gal-BrdU+ PTCs. 10 days after HgCl2 treatment, greater than 25% of PTCs were derived 
from NFATc1-P2-Cre PTCs. The number of PTCs that label X-Gal-BrdU+ does not 
change significantly throughout the time course consistent with results for PCNA staining 
shown in Figure 2.7. These data indicate that the PTCs that are labeled by the NFATc1-
P2 enhancer serve as a progenitor population that proliferates to help repair the damaged 
proximal tubule segment of the nephron. Furthermore, the close approximation of 
NFATc1-P2-Cre positive cells and their X-Gal+BrdU+ progeny suggests that the damaged 
PTC segment is regenerated by clonal expansion of an apoptosis-resistant subpopulation 
of cells that reside in the proximal tubule. 
 
Discussion 
 Using NFATc1-P2-LacZ mice, we identified a subpopulation of resident PTCs 
that express the reporter following HgCl2 injury and these cells are resistant to apoptosis. 
Using a novel transgenic reporter mouse line, NFATc1-P2-Cre, we identified a resident 
subpopulation of PTCs that serve as a progenitor cell population to regenerate the 
damaged proximal tubule segment.   This study provides the first in vivo experimental 
evidence using transgenic mouse lines to define a resident proximal tubule cell 
population repopulates the damaged proximal tubule segment following an AKI.  
 The NFATc1-P2-LacZ transgenic line was created in order to characterize the 
expression of the autoamplification of NFATc1 as marked by reporter activation (Zhou et 
al., 2005). This line was further characterized to recapitulate the endogenous expression 
of NFATc1 in the developing endocardium. Although we have not been successfully able 
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to report enhanced NFATc1 expression in the proximal tubule segment using antibodies, 
we believe these genetic studies provide a more sensitive method of NFATc1 expression 
and that the expression of NFATc1-P2-LacZ recapitulates endogenous NFATc1 
expression in the PTC after injury. As discussed in Chapter II, we were unable to 
document a change in NFATc1 protein expression by immunohistochemistry using 
currently available antibodies. This is at least partially the result of the inefficiency of this 
antibody (mouse monoclonal 7A6) when used for immunohistochemistry as experienced 
in our laboratory and others. In addition, we have previously documented a basal level of 
NFATc1 in normal PTCs prior to injury. The current study attempted to delineate an 
increase in autoamplification of NFATc1 expression above that detected in normal cells 
and thus it is not surprising that an increase of NFATc1 (verses the presence or absence 
of NFATc1) was not possible given the limitations of this antibody in 
immunohistochemical studies. 
This study provides additional insights into the basic mechanisms of PTC 
regeneration and repair following acute toxic insult. The injured kidney must undergo a 
program of regeneration and proliferation in order to restore renal function. The precise 
origin of cells that repair the damaged PTCs is unknown. It has been postulated that these 
cells arise from either adjacent less injured cells, a proximal stem cell population, or an 
external stem cell population circulating in the blood stream (Gupta et al., 2006; Morigi 
et al., 2006b; Sagrinati et al., 2006). The identification of an adjacent less injured 
population of progenitor cells has been difficult to identify because such a population 
remains phenotypically indistinguishable from their terminally differentiated 
counterparts. Our use of the NFATc1-P2-LacZ and NFATc1-P2-Cre mice suggest a 
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subpopulation of resident PTCs, which we identified using the NFATc1-P2 enhancer, act 
as progenitor cells that are resistant to apoptosis. This population subsequently undergoes 
proliferation to reconstitute a significant number of the damaged proximal tubule cells.  
Recent work has described a role for NFATc1 in controlling the quiescence and 
proliferation of stem cells found in the hair follicle (Horsley et al., 2008). NFATc1 
expression is activated by BMP signaling and represses CDK4 signaling in order to 
maintain stem cell quiescence and when the stem cells are activated to grow a hair, 
NFATc1 is downregulated, removing the repression of CDK4 and allowing proliferation. 
When Horsley et al. inhibited NFATc1/calcineurin signaling by deleting a conditional 
allele of NFATc1 or treated mice with CsA, the quiescent phase of the stem cell was 
removed resulting in rapid hair growth (Horsley et al., 2008). In contrast, Runx1, a 
protein required for blood formation, was conditionally deleted in keratinocytes. These 
mice produced normal hair follicles during development but the stem cells failed to 
proliferate and were trapped in the quiescent phase and therefore unable to sustain hair 
growth past 3 weeks of age. Following repeated periods of skin injury and repair, WT 
and Runx1 conditional knockouts had skin hair growth at the injured area and adjacent 
areas; however, Runx1 conditional knockouts eventually reentered the quiescent phase. 
The Runx1 mutant phenotype emphasizes the differences in hair growth that occurs 
during development compared to hair growth triggered by injury (Osorio et al., 2008). 
Taken together, these studies suggest a role for NFATc1 in the maintenance of 
quiescence and proliferation of stem cells in the hair follicle. Therefore, we hypothesize 
that NFATc1 may play a role in the regeneration of the proximal tubule segment after 
injury. 
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CHAPTER V 
 
ISOLATION AND CHARACTERIZATION OF PROXIMAL 
TUBULE PROGENITOR CELLS 
 
 
Introduction 
 The source of the progenitor cells that proliferate to regenerate the PTCs 
following an AKI is a clinically important question as described in Chapter I. The source 
of these cells has been proposed to come from one of three sources: BMCs circulating in 
the blood stream that undergo migration and transdifferentiation to repopulate the 
proximal tubule, adjacent uninjured cells that undergo MET and/or transdifferentiation 
adopting an epithelial phenotype, or less injured PTCs that self-renew. In Chapter IV, I 
presented data using NFATc1-P2-Cre mice crossed onto the R26R reporter line to show 
that the NFATc1 enhancer was activated in a subpopulation of proximal tubule cells that 
do not undergo apoptosis and proliferate to regenerate the damaged kidney following 
AKI. This is the first reported use of transgenic model system to identify a population of 
self-renewing proximal tubule progenitor cells (PTPCs) and introduces many questions. 
How does the gene expression profile for PTPCs differ from the gene expression profile 
of non-progenitor PTCs? Do the PTPCs have “stemness” - expressing markers associated 
with multipotent stem cells? Are these PTPC differentiated PTCs or do they share a 
common expression profile with developmental proximal tubule precursors?  
 To address these questions we created a single cell suspension of the renal cortex 
and used FACS to isolate the PTPCs demonstrating NFATc1 enhancer/reporter 
expression before and after HgCl2 induced AKI. Labeling proximal tubules with a 
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fluorescent reporter is key to the isolation of the progenitor population by flow 
cytometry. A transgenic line expressing a fluorescent reporter protein under the control of 
the NFATc1 enhancer/regulatory element is not available. Therefore, we initially used 
NFATc1-P2-LacZ mice to address the question: how does the gene expression profile of 
labeled PTPCs actively expressing the NFATc1 reporter differ from unlabeled PTCs? 
However, incorporation of a fluorescent dye required to sort the NFATc1-P2-LacZ 
PTPCs was toxic (see below). We altered our experimental approach to use the NFATc1-
P2-Cre mice crossed with mice that had a conditional fluorescent GFP reporter. 
 We then isolated mRNA from GFP+ PTCs and GFP– PTCs and performed Real-
time PCR on candidate genes to characterize the expression of proximal tubule, stem cell, 
and developmental markers. Our results show that the GFP+ PTCs have a 2-fold increase 
in NFATc1 expression compared to the GFP– PTCs. Furthermore, the GFP+ PTCs have 
increased expression of genes identifying them as differentiated proximal tubules (AQ-1, 
KAP, KSP, Lim1), have increased expression of stem cell markers (c-Myc, Klf-4, Nanog, 
Oct-4, Sox-2), proliferative (CDK4) and genes characteristic of early tubular 
development (BMP-2, BMP-4, BMP-7, Pax-2, Wnt-4, Wnt11). This analysis confirms 
that the GFP+ PTC population - comprised of PTPCs accentuated by NFATc1 and their 
progeny - have a unique gene expression profile and suggests that this population could 
be targeted to improve clinical outcomes of acute and chronic renal failure.  
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Methods 
 
HgCl2 induced AKI 
 All experiments were performed on 8-10 week old female mice. Primer sequences 
used to genotype mice are listed in Table 2.1. A single subcutaneous dose of 12 mg/kg 
HgCl2, a 1.5 fold increase compared to the dose used in previous Chapters, was 
administered in order to produce a similar injury in mice on a B6D2F1//C57BL/6 mixed 
genetic background.  
 
Protocol for FACS with NFATc1-P2-LacZ mice and ImaGene Red substrate 
 Kidneys from 3 mice were dissected removing the renal capsule and papilla. The 
remaining cortex was minced into 1mm3 pieces, and placed in 30 ml of ice-cold Krebs-
Henseleit saline (KHS, pH 7.4, containing 115 mM NaCl, 24 mM NaHCO3, 5 mM KCl, 
1.5 mM CaCl2, 10 mM MgSO4, 2 mM NaH2PO4, 10 mM HEPES, 5 mM glucose, 1 mM 
alanine) with 1.5% fetal bovine serum (KHS+). After 3 washes with KHS+, the tissue 
was digested in KHS+ supplemented with 7.5 mg/ml collagenase B (Roche), 1.2 U/ml 
dispase II (Roche), 0.01% DNAse I (Invitrogen) for 20 minutes in a 37˚C water bath 
(ideally with shaking at 40rpm). A 23 G needle and syringe were used to further digest 
the tissue, passing the digested mix through the needle 5-10 times. Red blood cells were 
lysed using 0.5 ml/kidney of red blood cell lysing buffer (Sigma), incubated for 1 minute, 
diluted with KHS+, and centrifuged at 1000 rpm for 5 minutes. This step was repeated if 
necessary.  The resulting single cell suspension was strained through a 40um filter (BD 
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Falcon) and washed 3-times with KHS+. The kidney digestion protocol was adapted from 
Challen et al. and Vinay et al. (Challen et al., 2006; Vinay et al., 1981).   
 
ImaGene Red C12RG substrate staining (Invitrogen) 
 Cells are resuspended 106/ml in 10 mM HEPES, 2% FBS. The supplied 
chloroquine reagent (1:100, 300 uM final concentration) was added and incubated for 30 
minutes at 37˚C. ImaGene Red substrate and FITC labeled LTL (2 mg/ml, Vector) are 
added (1:100, 1:1000, respectively) and incubated at RT for 30 minutes. The mixture was 
washed twice with KHS+ buffer and resuspended in 106/mL KHS+. 
 
Protocol for FACS with NFATc1-P2-Cre mice 
 Five days after treatment with HgCl2, kidneys from 3 mice were dissected, renal 
medulla removed, cortex minced into 1 mm3 pieces, and washed 3 times with 30 ml of 
ice-cold KHS+. The minced tissue was digested in 10ml of KHS+ containing 0.05% 
collagenase type I (5 mg/ml, Sigma), 0.1% DNase I (RNase-free, Invitrogen), and 0.01% 
soybean trypsin inhibitor (Sigma) for 45 minutes in a 37˚C water bath (ideally with 
shaking at 40 rpm). The suspension was filtered through a 100 um sieve (BD Falcon). 
The filter was washed with 30 ml of KHS+ and centrifuged at 1000 rpm for 30 seconds 
(Beckman Allegra 2IR) and repeated. Red blood cells were lysed in red blood cell lyses 
buffer (Sigma, 0.5 ml/kidney), mixed gently for 1 min, diluted with KHS+, and 
centrifuged at 1000 rpm for 5 minutes. This step was repeated if necessary and washed 
with KHS+. The tissue was resuspended in 0.25% trypsin (Gibco) diluted in KHS+, 
incubated 4 times at 37˚C for 5 minutes and pushed through a 23 G syringe 10-times 
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between incubations. Undigested tubules were removed by with a 40 um sieve, and the 
single cell suspension was washed with KHS+ 3 times. 
 Cells (106/ml) were incubated in biotinylated-LTA lectin (Vector, 2 mg/ml) 
prepared 1:1000 (2 ug/ml) in KHS+ buffer on ice for exactly 30 minutes. The labeled 
solution was washed twice with KHS+. Cells were then incubated in streptavidin-APC 
(Allophycocyanin, Molecular Probes 1 mg/ml) prepared 1:1000 (1 ug/ml) in KHS+ 
buffer on ice for exactly 15 minutes. The labeled solution was washed twice with KHS+. 
The cells were resuspended 107/ml in KHS for analysis and in KHS+ for cell sorting with 
1 µL PI/ml. The labeled cells were covered with foil to protect from light.  
 
Fluorescence activated cell sorting (FACS) 
 Flow Cytometry experiments were performed in the VMC Flow Cytometry 
Shared Resource.  The VMC Flow Cytometry Shared Resource is supported by the 
Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease 
Research Center (DK058404).  
 For each analysis or sort the following controls were prepared:  
• Unstained control – A single kidney cell suspension was prepared as described 
above using a nonfluorescent mouse (genotype Cre-/GFP+ or Cre+/GFP-) and this control 
was used to compensate for the natural fluorescence of the cell population. 
 Single color controls were prepared in order to individually optimize the voltages 
used with the photo multiplier tube for each fluorochrome. 
•  Propidium Iodide (PI) control – Cell viability was recorded as the percentage of 
cells that exclude PI, which crosses the extracellular and nuclear membranes and 
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intercalates into double stranded DNA of dead/dying cells. 1 ml of the cell suspension 
prepared from the nonfluorescent mouse was labeled with 1 µl of PI, vortex.  
• Allophycocyanin (APC) control – 1 ml of the cell suspension prepared from the 
nonfluorescent mouse was stained as described above with both biotinylated-LTL and 
streptavidin-APC. 
• Fluorescent reporter control – A 300 µL aliquot of the single kidney suspension 
prepared from the kidney sample to be sorted was removed before the sample was stained 
with biotinylated-LTL and streptavidin-APC. 
 
RNA extraction 
 Following each cell sort the volume was increased to 15 ml KHS+ and centrifuge 
for 5 minutes at 3000 rpm. RNA was isolated using the standard Trizol protocol  
(Invitrogen) followed by a second round of RNA purification was performed using the 
solid-state column based purification to yield a higher quality RNA (RNeasy Mini Kit, 
Qiagen). RNA quality and concentration was determined using capillary electrophoresis. 
(RNA 6000 Nano LabChip Kit and Bioanlyzer, Agilent). cDNA was prepared from 0.35 
ug of total RNA using oligo-dT16 primer following the manufacturer’s protocol 
(Transcriptor Reverse Transcriptase, Roche).  
 
qRT-PCR 
 qRT-PCR was performed as described in Chapter 2 with primer sequences in 
Table 5.1.  Three independently sorted samples were used for quantification. Significant 
changes in expression were calculated using the nonparametric Mann-Whitney U test.  
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Table 5.1 Oligonucleotides for qRT-PCR analysis of GFP+ PTC and GFP– PTC 
expression profiles.  
Marker gene Primer sequence     Annealing  Product                  Fragment 
       Temperature (C˚)    Temperature (C˚)   length(bp) 
 
Aquaporin-1     CATTCTCTCGGGCATCACCT   58           80     176 
           GGGCTGAGCCACCTAAGTCTC 
BMP-2  TGAGCGCAATCTCCATGTTGTACC  55           81     105 
  ATTCTTGCTGTGCTAACGACACCC 
BMP-4  TGGCTGATCACCTCAACTCAACAA  55           81     125 
  CCAGGTACAACATGGAAATGGCAC 
BMP-7  TGTGGCAGAAAACAGCAGCA   54           81     105 
  TCAGGTGCAATGATCCAGTCC 
Cadherin-11      ATGGGGCACTGTTGTCCTGT   58           83     219 
           CCTCACCACCCCCTTCATCATCATAG 
CDK-4  CTCGTACCGAGCTCCTGAAG   55           85     351 
  TTCTGCAGGTAGGAGTGCTG  
c-Myc  AAGCAGATCAGCAACAACCGCAAG  55           85     100 
  TCCTCTGACGTTCCAAGACGTTGT 
GAPDH  CACTGGCATGGCCTTCCGTG   55           80     253  
       AGGAAATGAGCTTGACAAAG 
KAP  CTTCCTCGTTCTTTCTTCTTTG   54           81     429 
  ACTGTGGCTTTCCCCCTGTC 
Klf-4  ACCTTTCACACTGTCTTCCCACGA  55           83       86 
  TCACAAGCTGACTTGCTGGGAACT 
KSP  CAACGATTCCCACGCCTACC   58           82     130 
  GCAGCGACACACAATCACTTTG 
Lim-1  CGTAGGGGACCCCGGACCACGATCA  58           88     389 
  AGGGGCCGTTGGGGATGAGTTCGCC 
Nanog  AAGCCAGGTTCCTTCCTTCTTCCA  55           83     173 
  AGGTCAGGAGTTCAAATCCCAGCA 
Nephrin  ATCGCCAAGCCTTCACAGGTA   58           85     155 
  GACCTCAGGCCAGCGAAGG 
Nfatc1           GGTGGCCTCGAACCCTATC    55           86     204 
       TCAGTCTTTGCTTCCATCTCCC   
Oct-4  GGCGTTCTCTTTGGAAAGGTGTTC  58           80     312 
  CTCGAACCACATCCTTCTCT 
Pax-2  AGACTCGGCCGGAGACTGAGC   62           88     461 
  GGGCTGGGCGAGTTAGGACTG 
Pax-6  GAGAAGAGAAGAGAAACTGAGGAACCAGA  58           80     201  
  ATGGGTTGGCAAAGCACTGTACG 
Pax-8  TGTTTGCTTGGGAGATCCGGGAC   58           85     351  
  CCACTGCTGCTGCTCTGTGAGTCGAT 
Podocalyxin CCAGAGGAAGGACCAGCAA   58           80     120 
  CACCTTCTTCTCCTGCATCT 
Pod-1  CCAAGCTGGACACTCTCAGG   58           82     120 
  CCATAAAGGGCCACGTCAG 
Sox-2  GAGGAAAGGGTTCTTGCTGGGTTT  55           72     142 
  GGTCTTGCCAGTACTTGCTCTCAT 
Wnt-4  GTGGCCAACCTGGCGGAAGGG   65           88     491 
  GTGGTGCCCAGCTGGCCATCG 
Wnt-11  GTGAAGTGGGGAGACAGGCT   58           83     119 
  CACGTCCTGGAGCTCTTGC 
 
Sequences are listed in the order antisense, sense-primer. Primer sequences for Aquaporin-1, KSP, Nephrin, 
Podocalyxin, Pod-1, Wnt-11 (Bruce et al., 2007), Cadherin-11, Oct-4, Pax-6 (Vigneau et al., 2007), CDK-4 (Schmidt et 
al., 2007), and Lim-1, Pax-8 (Kramer et al., 2006) have been previously published. BMP2, BMP4, c-Myc, Klf-4, 
Nanog, and Sox-2 primers were graciously provided by the laboratory of Trish Labosky.  
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Experimental mouse models for PTPC isolation 
 
NFATc1-P2-LacZ mice  
 Our initial experimental approach was to use NFATc1-P2-LacZ mice and sort β-
Gal+ PTPCs and compare them to β-Gal– PTCs. This approach allowed us to isolate the 
PTPC population actively expressing β-Gal by the NFATc1 enhancer throughout the time 
course of AKI. A complication of this approach was the requirement for incorporation of 
a fluorescent β-Gal substrate, ImaGene red, necessary for sorting. Because the β-Gal 
expressed by NFATc1-P2-LacZ mice is localized to the nucleus, the fluorescent substrate 
was required to cross both the extracellular and nuclear membranes. The ImaGene red 
substrate incorporated into cells as seen by fluorescent microscopy (data not shown). 
However, further staining with PI revealed that the staining protocol necessary to 
incorporate the ImaGene substrate was toxic as fluorescently labeled cells retained the PI 
label (data not shown).  
 
NFATc1-P2-Cre//R26R-EYFP mice 
 As labeling of proximal tubules expressing a fluorescent reporter is key to the 
isolation of the progenitor population by flow cytometry, we adapted our experimental 
approach to use the NFATc1-P2-Cre mice and a conditional fluorescent reporter system, 
R26R-EYFP (enhanced yellow fluorescent protein) (Srinivas et al., 2001). In this line, an 
EYFP cDNA floxed by loxP sites has been targeted to the ROSA26 locus. FACS has been 
successfully used in this cell line to isolate numerous cell types including pancreatic α-
cells (Quoix et al., 2007).  
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 An alternative labeling method was proposed to use an antibody to label the Cre 
reporter. However, similar to the problems we experiences trying to label the nuclear 
localized LacZ, Cre recombinase is nuclear localized thus trying to label cells that are 
actively expressing Cre would involve transport of an antibody or substrate across the 
nuclear membrane and was equally toxic. 
 As described in the previous chapter, the NFATc1-P2-Cre expressing cells should 
recombine the EYFP locus and express EYFP constitutively in all progeny. The EYFP 
positive cell population would be a heterogeneous population consisting of EYFP+ 
PTPCs and EYFP+ progeny. We would expect the labeled PTPC progeny to have a gene 
expression profile that is distinct from both the labeled PTPC and EYFP– PTC 
populations. 5 days after HgCl2 injury, FACS analysis revealed that the R26R-EYFP 
reporter mice had fewer cells that had recombined the EYFP locus (data not shown) 
compared to the anticipated number based on our previous quantification (Fig. 4.4H). 
This was due either to the inefficiency of the NFATc1-P2-Cre to recombine the R26R-
EYFP allele or from weak EYFP expression in the proximal tubule.  
  
NFATc1-P2-Cre//Z/EG mice 
 Finally, we altered our strategy to use a robust fluorescent reporter, the transgenic 
Z/EG mice. The Z/EG transgenic mice constitutively express a floxed lacZ reporter and 
stop codon under the control of the CMV enhancer/chicken β-actin promoter and, 
following Cre mediated recombination, the lacZ gene and polyadenylation sequence is 
excised allowing the second reporter, green fluorescent protein (GFP) to be expressed 
constitutively (Novak et al., 2000). When NFATc1-P2-Cre//Z/EG mice are treated with 
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HgCl2 to induce AKI, the NFATc1-P2-Cre should be activated in the PTPCs activating 
expression of GFP, and because GFP expression is constitutive, all progeny will express 
GFP allowing for further analysis of this lineage. GFP+ and GFP– populations were 
analyzed using FACS, as described below.  
 
Results 
 
FACS with NFATc1-P2-Cre//Z/EG mice 
 NFATc1-P2-Cre//Z/EG treated with HgCl2 were analyzed after 5 and 10 days and 
compared to mice that were not treated with HgCl2. Cryosections were stained with X-
Gal to report LacZ activity and GFP activity was analyzed in kidney cortex slices. Before 
treatment with HgCl2, NFATc1-P2-Cre was not expressed in any tubule epithelial, 
glomerular, or interstitial cell population as seen by ubiquitous X-Gal staining suggesting 
that there was no recombination (Fig. 5.1A). Ten days after injury, ubiquitous X-Gal 
staining was observed in distal tubules and in the glomerulus (Fig. 5.1B, inset) but not in 
proximal tubules.  The increased  dose of  HgCl2  administered to NFATc1-P2-Cre//Z/EG  
mice increased the number of proximal tubules that demonstrate recombination and 
excision of the LacZ reporter compared to R26R reporter recombination presented in 
Chapter IV. At an earlier time point 5 days after injury, GFP expression was observed in 
the outer cortex (OC) and inner cortex (IC, Fig. 5.1C). GFP expression was observed in 
proximal tubules and no GFP expression was observed in the glomeruli (Fig. 5.1D). GFP 
expression was also observed in other cell types. We would predict that the additional, 
non-PTCs  populations  expressing GFP  are endothelial cells  that form  interstitial blood  
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Figure 5.1. Expression of LacZ and GFP in NFATc1-P2-Cre//Z/EG before and
after HgCl2 injury. A. Before HgCl2 treatment, NFATc1-P2-Cre is not expressed in
any tubule epithelial, glomerular, or interstitial cell population as seen by X-Gal
staining. B. 10 days after injury, X-Gal staining is observed in distal tubules and in the
glomerulus (inset) but not in proximal tubules. C. 5 days after injury, GFP expression
observed in the outer cortex (OC) and inner cortex (IC). 300mm optical slice. D. High
power magnification of shows staining in the proximal tubule (arrowheads) and no
staining in the glomeruli (red ellipses). 75um optical slice. Magnification: A,B 100X;
C, 40X; D, 200X.
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vessels and smooth muscle cells, as the NFATc1-P2-LacZ reporter was expressed in this 
population. Attempts to use anti-GFP antibody for dual immunofluorescence in 
combination with other cell specific antibodies to confirm the identity of these 
populations was unsuccessful. However, the single cell population was able to be labeled 
with PTC specific biotinylated-LTL and streptavidin-APC allowed for PTCs to be 
distinguished from non-PTCs by FACS analysis.  
 Populations of cells, GFP+ PTCs and GFP– PTCs were analyzed and sorted by 
flow cytometry before treatment with HgCl2 and 5 days after HgCl2 induced AKI (Fig. 
5.2). We calculated the percentage of GFP+ PTCs and GFP– PTCs in the total cell 
population - all cellular events recorded that includes both PTCs and non-PTCs - and as 
the percentage of the defined cell population – restrictions placed on the total cell 
population to gate for cell viability, cell size, and intensity of the fluorescent labeling 
(Table 5.2). The viability of the single cell suspension was measured using PI labeling to 
record the percentage of cells that exclude PI. We documented that 83.1% and 67.9% of 
the defined cell population was viable at day 0, and day 5, respectively. Treatment with 
HgCl2 did not significantly reduce viability in either the total cell population or the 
defined cell population.  
 Proximal tubule cells were labeled using biotinylated-LTL and streptavidin-APC. 
We treated NFATc1-P2-Cre//Z/EG mice with HgCl2 and sorted GFP+ PTCs and GFP– 
PTCs 3 days after injury. There was an insignificant increase in the GFP+ PTC 
population, which comprised 0.45% of the defined population of cells and 0.1% of the 
total cell population. We were unable to isolate RNA from this population, and therefore 
used the samples isolated at day 5 for gene profile analysis. Treatment with HgCl2 did not 
Figure 5.2. Quantification of FACS to sort GFP+ PTC and GFP– PTPC. GFP+
PTCs are significantly increased 5 days after HgCl2 treatment compared to untreated
samples at day 0 (‡, p=0.0001, student’s T-test). GFP was constitutively expressed
following NFATc1-P2-Cre expression and recombination of the Z/EG transgenic
allele. APC fluorescently labeled proximal tubule cells using biotinylated-LTL and
streptavidin-APC. The same numbers of events are shown in each dot plots and the
percentages are representative of the viable cells sorted in 3 independent samples.
Day 0
52.3% 0.3%
Day 5
49.4% 3.4%‡
107
 108 
Table 5.2. FACS: percentage of viable, GFP+ PTC, and GFP– PTC populations.  
Time Point  Sample           Defined Cells (%)       Total Events (%)  
 
Day 0   Viable cells       83.1 ± 1.7    18.5 ± 7.0  
   APC+GFP–       52.3 ± 9.6    16.6 ± 6.6  
   APC+GFP+     0.3 ± 0.1               0.13 ± 0.07  
 
Day 5   Viable cells       67.9 ± 2.1    42.5 ± 0.6  
   APC+GFP–   49.4 ± 8.8    25.3 ± 7.9  
   APC+GFP+     3.4 ± 0.2‡      1.7 ± 0.2†    
 
Percentages are for 3 independently sorted samples; mean ± SEM. Statistics comparing Day 0 and Day 5 cell 
populations using student’s T-test. ‡p = 0.0001, †p=0.003. 
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significantly change the number of GPF– PTCs (APC+GFP–) in the total cell population 
or the defined cell population 5 days after injury. Prior to treatment with HgCl2, 0.3% of 
the sorted population was GFP+, suggesting that this population is a quiescent progenitor 
population (discussed in Chapter VI). 5 days after treatment with HgCl2, there was a 
significant increase in the number GFP+ cells as 3.4% of the defined cell population was 
GFP+ PTCs (APC+GFP+).  
 
Nfatc1 transcription is increased in GFP+ PTCs 
 After obtaining 3 independently sorted populations of GFP+ PTCs and GFP– 
PTCs 5 days after HgCl2 injury, gene expression profiles were analyzed using qRT-PCR. 
Nfatc1 expression was increased 2-fold in the GFP+ PTCs compared to GFP– PTCs (Fig. 
5.3). Nfatc1 expression accentuated in the GFP+ PTCs after HgCl2 induced AKI 
confirmed that the increase in Nfatc1 observed previously over the time course of AKI in 
renal cortex samples and increased protein in isolated proximal tubule (Fig. 2.3, Fig 2.5) 
was in the GFP+ PTCs.  
 
 
GFP+ PTCs are fully differentiated proximal tubules and have decreased transcription 
of mesenchymal and glomerular markers 
 
 We analyzed the transcription of genes expressed in fully differentiated proximal 
tubules: Aquaporin 1, KAP, KSP, and Lim1 (Fig. 5.3). Aquaporin 1 is expressed in 
convoluted and straight proximal tubules and the thin descending limb (Sabolic et al., 
1992).  KAP or kidney androgen-regulated protein is expressed in the S3 segment of the 
proximal tubule because and in the S1/S2 segment of the proximal tubule in male mice 
and   in   androgen-induced   females   (Meseguer and Catterall, 1990).   KSP   or  Kidney  
Figure 5.3. qRT-PCR analysis of NFATc1 and markers of tubular development,
stem cells, differentiated proximal tubules,  and other renal cell populations in
GFP+ PTCs compared to GFP– PTCs.  cDNA samples were derived from 3
independently sorted GFP+ PTC and GFP– PTC samples. Fold change in expression
of GFP+ PTCs compared to GFP- PTCs is represented as mean ± SEM. (*, p<0.05,
Mann-Whitney U)
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specific protein (also known as cadherin 16) is expressed in proximal and distal tubules 
(Igarashi, 2003). Lim1 alternatively named Lhx1, plays an important role in patterning 
the segmental tubular structures of the nephron (Kobayashi et al., 2005). The expression 
of these  proximal  tubule  markers  were  either  slightly  increased (AQ1, KAP, LIM) or 
unchanged (KSP) in the GFP+ PTCs compared to the GFP– PTCs suggesting that GFP+ 
PTCs are differentiated proximal tubules and are not undergoing a program of 
dedifferentiation or EMT.  
 
Transcription of developmental markers is increased in GFP+ PTCs 
 Expression of genes known to be expressed during kidney development in the 
condensed metanephric mesenchyme (Pax-2, Wnt-4), developing tubules (BMP7, Lim-1, 
Wnt4) and ureteric bud tips (BMP7, Pax-2, Wnt11) were increased in GFP+ PTCs 
compared to GFP– PTCs (Fig. 5.3). Pax-2, the paired-box DNA-binding transcription 
factor expression was observed in stem cells isolated from the metanephric mesenchyme 
(Gupta et al., 2006). BMP-7 expression was not observed in adult proximal tubule cells, 
but has been proposed to possibly have therapeutic benefit following AKI (Kopp, 2002).  
Adult rats administered125I-labeled BMP7 showed that the labeled BMP7 bound to 
proximal convoluted tubules and was used to identify BMPR-II in the proximal tubule 
(Bosukonda et al., 2000) and significant increase in BMP7 expression in the PTPCs may 
contribute to the repair process. 
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Transcription of stem cell markers is increased in PTPCs 
 Induced pluripotent stem cells (iPSC) have been shown to be derived from murine 
and human somatic cells by inducing the expression of several ES cell genes including c-
Myc, Klf-4, Nanog, Oct-3/4, and Sox-2 (Nakagawa et al., 2008; Okita et al., 2007; Yu et 
al., 2007b). We analyzed the expression of these stem cell markers c-Myc, Klf-4, Nanog, 
Oct-4, and Sox-2 using qRT-PCR in order to evaluate the “stemness” of the GFP+ PTCs 
(Fig. 5.3). Expression of c-Myc, Klf-4, and Nanog was increased 1.5-fold in the GFP+ 
PTCs compared to GFP– PTCs. c-Myc is a transcription factor that regulates proliferation 
and constitutive expression of c-Myc in iPSC leads to formation of teratomas. Klf-4 is a 
member of the Kruppel-like factor family of zinc-finger proteins that share amino acid 
sequence homology with the Drosophila embryonic pattern regulator Kruppel. Nanog 
was expressed in pluripotent stem cells in vivo and in vitro and loss of Nanog expression 
was associated with stem cell differentiation.  
 Expression of Oct-4 and Sox-2 was increased 2-fold in the GFP+ PTCs compared 
to GFP– PTCs (Fig. 5.3). Oct-3 and Oct-4 belong to the octamer-binding (Oct) family of 
transcription factors also known as the POU family of transcription factors expressed in 
pluripotent undifferentiated embryonic and adult stem cells. Sox-2, a member of the sex-
determining region of the Y chromosome (SRY-related) high-mobility group (HMG) box 
(SOX) family of transcription factors, maintains the self-renewal of undifferentiated stem 
cells. The increased expression of these genes in the GFP+ PTCs is suggestive that this 
subset of PTCs represents a progenitor cell population.  
 In addition, we looked at expression of BMP2, BMP4 and cyclin-dependent 
kinase 4 (CDK4) as these genes have recently been shown together with NFATc1 to 
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control quiescence and proliferation of stem cells in the hair follicle (Horsley et al., 
2008). In hair follicle bulge cells, BMP signaling increased expression of NFATc1 in turn 
inhibiting CDK4 activity, maintaining quiescence in these stem cells and attenuation of 
NFATc1 signaling increased CDK4 expression and activated proliferation in the stem 
cells (Horsley et al., 2008). CDK4 inhibits proliferation by blocking the G0-G1 transition 
and progresses proliferation by promoting G1-S [reviewed in (Malumbres and Barbacid, 
2005)]. In mice, CDK4 expression was increased in renal tubule epithelial cells during 
the phase of proliferation following I/R injury (Park et al., 1997). The qRT-PCR analysis 
performed showed a significant increase in CDK4 expression, a 2.5-fold increase in 
BMP2 expression, and slight increase in BMP4 expression in the GFP+ PTCs compared 
to GFP– PTCs.  
 Because the GFP+ PTCs express markers of pluripotent ES cells, we questioned if 
they had potential to adopt other fates in order to repair other damaged cell populations of 
the kidney. Genes expressed in mature podocytes (Nephrin, Pod-1, Podocalyxin) and 
metanephric mesenchyme (Cadherin11) were downregulated in GFP+ PTCs. Expression 
of Nephrin was significantly decreased in the GFP+ PTC population. The decrease in 
expression of glomerular and mesenchymal markers further supports that the GFP+ PTCs 
are a differentiated progenitor cell population and that the GFP+ PTCs are not initiating 
transformation to undergo EMT.  
 
Discussion 
 Here we describe the use of flow cytometry to isolate GFP+ and GFP- PTCs from 
NFATc1-P2-Cre//Z/EG mice after HgCl2 induced AKI. The NFATc1-P2-Cre is a novel 
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transgenic resource and we believe that we are the first to describe the use of a transgenic 
model system to identify and perform lineage tracing on a renal progenitor cell 
population that regenerates the damaged nephron following AKI. 
 GFP+ PTCs and GFP– PTCs were isolated in order to characterize the gene 
expression profile that defined the PTPCs accentuated by NFATc1 expression and their 
progeny following AKI and to identify how that expression profile differed from the 
GFP– PTCs. qRT-PCR performed on these cell populations showed that NFATc1 
expression was increased in the GFP+ PTCs. In addition, the GFP+ PTCs had increased 
expression of differentiated proximal tubule markers, tubular development markers, and 
markers of pluripotent stem cells. It is possible that adult renal stem cell population, 
MRPC previously identified by Gupta et al. could be the population of PTPCs identified 
here (Gupta et al., 2006). MRPC were identified to be a tubular epithelial cell population 
characterized by expression of Oct-4 and Pax-2 and the gene expression profile of the 
GFP+ PTCs showed increased transcription of Oct-4 and Pax-2 compared to GFP- PTCs. 
However, this gene expression profile is complex and further analyses are necessary to 
determine the differences in the gene expression profile of the GFP+ progeny and GFP+ 
PTPCs accentuated by NFATc1 and the localization of proximal tubule, stem cell, and 
developmental markers in each population, as proposed in Chapter VI.  
 Lineage analysis of the NFATc1-P2-Cre//R26R mice over the HgCl2 time course 
allowed us to estimate the heterogeneity of the GFP+ PTC population (Fig. 4.4H). As 
shown in Figure 4.4G, at day 5 there was an increase in number of XGal+BrdU– progeny 
compared to XGal+BrdU+ PTPCs. Thus, we would estimate that the population of GFP+ 
PTCs contains more GFP+ progeny than GFP+ PTPCs accentuated by NFATc1. 
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However, this estimate was approximate due to the short 2-hour BrdU pulse. The GFP+ 
PTC progeny could have a gene expression profile that is distinct from both the GFP+ 
PTPCs and GFP- PTCs, which could not be analyzed with this FACS analysis model 
system. 
 Our initial experimental design proposed to use NFATc1-P2-LacZ mice to 
characterize the gene expression profile that defined the subpopulation of PTCs 
accentuated by NFATc1 expression (PTPCs) compared to PTCs that were unlabeled. 
However, the fluorescent substrate required to label the NFATc1-P2-LacZ reporter for 
flow cytometry was toxic.  Subsequently, we used the NFATc1-P2-Cre mice crossed with 
conditional fluorescent reporter. The most significant limitation of this approach is that it 
results in identification and subsequent sorting of a heterogeneous population of cells. 
There are at least two distinct populations of cells that should be sorted: 1) the parent 
population and 2) the progeny. As expression of the NFATc1-P2-Cre labeled PTPCs as 
well as their progeny with GFP, we would be analyzing the difference in the gene 
expression profile that defines the GFP+ PTC – a heterogeneous population of PTPCs 
and their progeny- compared to GFP– PTCs.  
 A limitation to the use of the NFATc1-P2-Cre mice is that expression of Cre 
recombines the Z/EG reporter allowing for constitutive expression of GFP in a population 
of PTPCs, as described in Chapter IV, and the expression of the GFP reporter is inherited 
by their progeny. Therefore, our gene expression profile analyzed the changes in 
expression of candidate genes of the GFP– PTCs compared to the GFP+ PTCs – a 
heterogeneous population that contained the PTPCs accentuated by NFATc1 expression 
and their GFP+ progeny. This could explain the results of our gene expression profile 
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analysis where we measured increased expression of stem cell and tubular developmental 
markers, which are likely to be upregulated in the PTPC parent population and an 
increase in the expression of mature proximal tubule markers, which are likely to be 
upregulated in the progeny of PTPCs. The increase expression of CDK4 and Nfatc1 
suggest that regulation of cell cycle progression in PTPCs is likely via a different 
mechanism than in the bulge cells of the hair follicle. In GFP+ PTCs, BMP7 expression 
and CDK4 expression were significantly increased and act may act synergistically to 
promote progression through the cell cycle. In Chapter VI, I will outline future 
experiments and propose a new transgenic mouse line designed to isolate the PTPCs.  
 The data reported here should be important to the field of renal regenerative 
medicine, as this is the first report of a transgenic model system that has been used to 
genetically label a renal progenitor cell population and to monitor the subsequent 
proliferation and lineage analysis of this population in mice.  Most importantly, we 
identify a resident progenitor population of cells that is fully differentiated expressing 
relatively unchanged levels of proximal tubule specific genes yet increasing the 
expression of stem cell markers and markers of tubular development. Using the 
transgenic tools available we were able to isolate and characterize the gene expression 
profile of GFP+ PTPCs and GFP+ progeny cells compared to GFP– PTCs. However, 
characterization of the gene expression profile that defines the subpopulation of PTPCs 
accentuated by active NFATc1 expression following AKI will require derivation of new 
transgenic reporter lines and is addressed in the final chapter.  
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CHAPTER VI 
  
DISCUSSION AND FUTURE DIRECTIONS 
 
 The primary focus of my research was to determine the function of NFATc1 in 
murine renal proximal tubules over a time course of renal injury and regeneration. After 
documenting a phenotype in Nfatc1+/- mice, transgenic mice that express reporters under 
the control of NFATc1 regulatory elements were used to identify a resident population of 
PTPC. We analyzed the expression profile of candidate genes in this unanticipated 
population distinguished by accentuated NFATc1 expression. The work presented here 
lays the groundwork for studies to further characterize the role of NFATc1 in proximal 
tubule regeneration and should help advance the field of renal regenerative medicine by 
providing mechanisms to characterize this population of PTPCs. I will conclude with a 
discussion of the significance of identification of a self-renewing resident PTPC and 
suggest future experiments to further determine the function of NFATc1 in renal 
regeneration.   
 
Model for the role of NFATc1 in proximal tubule injury and repair 
 We propose a model for the regeneration of PTCs (Fig. 6.1). When the proximal 
tubule is exposed to an injury stimulus, some of the PTCs undergo apoptosis, a 
population of PTCs survive but do not proliferate, and a third PTPC population, 
genetically marked using the NFATc1-P2 auto-amplification/enhancer domain, is 
resistant to  apoptosis and  proliferates  under  a  program  of  self  renewal  to  repair  the  
Figure 6.1. The proposed model for the role of NFATc1 in regenerating PTCs. See
text for details.
NFATc1
Injury 
Apoptosis Apoptosis
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damaged proximal tubule. While this study does not allow us to determine the 
contribution of non-Nfatc1 expression cells to PTC regeneration, it does document that a 
significant portion of the regenerated PTCs are derived from NFATc1 progeny. Further 
investigation is warranted to delineate the molecular basis for PTC heterogeneity and to 
enhance the regenerative activity of the resident progenitor population. Regulation of 
NFATc1 activation could have therapeutic benefits by providing a possible target for 
regeneration following acute and chronic injury. By specifically altering NFATc1 in 
PTCs, it may be possible to pharmacologically separate the immunosuppressive and 
nephrotoxic effects caused by calcineurin inhibitors and other pharmaceuticals and 
overcome the nephrotoxicity of environmental/occupational toxins. 
 
NFATc1 in AKI and repair 
 
Genetic attenuation of NFATc1 
 When I began my thesis research to investigate the role of NFATc1 in proximal 
tubules, there was little known about expression of NFATc1 in the kidney. NFATc 
proteins were shown to be expressed in cortical tubules of adult mice and during tubular 
development and NFATc1 was shown to be expressed in mesangial cells grown in 
culture (Puri et al., 2004; Sugimoto et al., 2001). We adopted a simple and reproducible 
model of AKI achieved by administering a single bolus of HgCl2 in WT mice and mice 
with genetic deletion of one allele of Nfatc1, Nfatc1+/-. This modest attenuation of 
NFATc1  expression  resulted  in  increased  apoptosis  in PTCs, sustained tubular injury, 
delayed regeneration, and increased fibrosis in response to PTC injury. I further 
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demonstrated using qRT-PCR analysis and immunoblotting that NFATc1 mRNA and 
protein are upregulated during the period of regeneration following HgCl2 induced AKI 
in WT mice. NFATc1 mRNA and protein are decreased in the Nfatc1+/- mice during the 
period of regeneration suggesting that even a modest attenuation of NFATc1 perturbs the 
normal course of regeneration. 
 
Pharmaceutical attenuation of NFATc1 activity 
 Nfatc1+/- mice had a 20% reduction in transcription of Nfatc1 mRNA in the renal 
cortex and a 10% reduction of NFATc1 protein in the proximal tubule compared to WT 
before treatment with HgCl2. In response to HgCl2, we observed significant 
histopathological accentuation of renal injury. But, the serum creatinine and proliferation 
rates of the Nfatc1+/- mice were not significantly different compared to WT mice. This 
suggests that residual expression of NFATc1 in Nfatc1+/- mice is sufficient to maintain 
renal function. Because NFATc1 homozygous null mice die in utero from cardiovascular 
defects and are therefore not available for adult studies, we wanted to further reduced the 
amount of NFATc1 activity in the proximal tubule. WT mice were treated daily with CsA 
prior to and following HgCl2 induced AKI. Treatment with both CsA and HgCl2 resulted 
in elevated serum creatinine concentrations, interstitial fibrosis characterized by increased 
extracellular matrix deposition, and progression to renal failure and death not seen with 
either CsA or HgCl2 treatment alone.  
 Mice treated with 5mgCsA/kg had a 20% reduction in Nfatc1 transcription in the 
renal cortex, similar to Nfatc1+/- mice and mice treated with 10mgCsA/kg had a 40% 
reduction in transcription of Nfatc1 in the renal cortex before HgCl2 injury compared to 
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WT mice. Following HgCl2 treatment, Nfatc1 transcription was suppressed in both 
5mgCsA/kg and 10mgCsA/kg treated mice and was not significantly increased in 
10mgCsA/kg treated mice. However, because of the toxicity and high mortality in mice 
treated with both HgCl2 and 10mgCsA/kg and the pleiotropic effects of CsA, we were not 
able to attribute renal failure specifically to the severely damaged proximal tubule 
segment. Therefore, in order to address the requirement of NFATc1 expression in the 
proximal tubule segment during acute kidney injury, it will be necessary to develop a 
strategy for tissue specific and temporally regulated NFATc1 deletion. 
 
PTC specific gene ablation 
 Throughout my graduate career, we have been working with Dr. Bin Zhou to 
create a conditional floxed NFATc1 allele to remove the RHD and germ line 
transmission of a floxed NFATc1 allele has been established. During the preparation of 
this dissertation, Horsley et al published work with a conditional allele of NFATc1 
(Nfatc1fl) that was generated by flanking exon 3 with lox P sites, which excises the NHR 
domain following Cre mediated recombination (Horsley et al., 2008). An important issue 
that I was not able to address during my thesis work was how regeneration of the 
proximal tubule segment is affected when NFATc1 is not expressed in this population. 
To address this important question, mice containing the Nfatc1fl allele should be breed 
with R26R reporter mice and their progeny should be breed with mice containing a 
proximal tubule specific Cre, sglt2-Cre (Rubera et al., 2004). Sglt2 is a low-affinity 
sodium-dependent glucose cotransporter that is involved in glucose reabsorption in the 
S1, S2, and S3 segments of the proximal tubule (Tabatabai et al., 2001; Wright, 2001; 
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You et al., 1995). The sglt2-Cre strain of mice were created by fusing the 5’ upstream 
promoter region, the first exon, the first intron, and part of the second exon of sglt2 to the 
Cre coding sequence (Rubera et al., 2004). By crossing the sglt2-cre mice with R26R 
reporter mice, X-Gal staining confirmed proximal tubular specificity and importantly no 
Cre activity was detected in the lung, intestine, colon, liver, heart, brain, spleen, and 
muscle (Rubera et al., 2004). Nfatc1fl/fl//sglt2-Cre mice could be used to study the role of 
NFATc1 in all PTCs over the course of AKI and regeneration. We would expect to see 
intense injury in the proximal tubule segment marked by vast apoptosis, elevated serum 
creatinine levels and possible mortality.   
 Because the Nfatc1-/- mice die at E13.5, we were unable to study NFATc1 in later 
stages of renal development in vivo. In vitro organ culture experiments performed with 
E11.5 kidney rudiments isolated from WT, Nfatc1+/-, and Nfatc1-/- did not reveal obvious 
defects in branching of the ureteric bud (data not shown). Furthermore, in vitro 
metanephric culture conditions do not fully recapitulate in vivo renal development as the 
interstitium and glomeruli are not vascularized. To further investigate if NFATc1 causes 
renal defects, I engrafted WT and Nfatc1-/- E13.5 kidneys under the renal capsule of SCID 
mice. When engrafted under the renal capsule of adult SCID mice, the structural integrity 
of the transplanted embryonic kidney rudiment is preserved, normal structure of the 
glomeruli is maintained, wastes are excreted into the host tissue, and the engrafted tissue 
becomes vascularized by blood vessels of the host kidney (Hammerman, 2004). We did 
not identify abnormal renal development in Nfatc1-/- kidneys transplanted into normal 
hosts (data not shown). Thus, we would anticipate that deletion of NFATc1 in the PTC 
would not result in significant renal developmental abnormalities.  
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 We would expect Nfatc1fl/fl to be excised in utero as sglt2 is expressed in 
differentiated PTCs. Deletion of NFATc1 from PTCs may subsequently decrease 
nephrogenesis and result in post-natal renal failure or mortality, as discussed above. 
Alternatively, if sglt2-Cre is not efficient in deleting Nfatc1fl/fl, the Nfatc1fl allele could 
be deleted by crossing Nfatc1fl/fl mice with alternative Cre reporters such as Pax2-Cre to 
delete NFATc1 from the developing metanephric mesenchyme and Wolffian duct 
(Dressler et al., 1990; Ohyama and Groves, 2004) or KSP-Cre to delete NFATc1 in renal 
tubules, collecting duct and ureter (Shao et al., 2002). We would not expect conditional 
deletion of NFATc1 in this expanded population to attenuate nephrogenesis but may 
heighten renal injury following HgCl2 induced AKI.  
 
AKI and PTPC specific NFATc1 deletion 
 A different experimental approach would be to study the role of NFATc1 deletion 
in the PTPC population by conditionally deleting the Nfatc1fl/fl allele specifically in the 
PTPCs using the NFATc1-P2-Cre mice. NFATc1fl/fl//NFATc1-P2-Cre mice would 
develop normally as NFATc1-P2-Cre is not activated in this population until after HgCl2 
injury. Following AKI, we would expect to see ablation of the PTPC population and 
severe injury as we propose that the work presented here identifies a self-renewing 
progenitor cell population that is resident in the proximal tubule segment and regenerates 
the PTC segment following AKI. The qRT-PCR data presented in Chapter 5 suggests that 
NFATc1 controls cell-cycle progression. Therefore, NFATc1fl/fl//NFATc1-P2-Cre mice 
would have little if any proliferation following HgCl2 induced AKI as only a small 
percentage of unlabeled PTCs proliferate (Fig. 4.4). However, NFATc1-P2-Cre is 
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expressed in endocardial cells and attenuation of NFATc1 is likely to result in embryonic 
lethality due to cardiac valve defects as previously described (de la Pompa et al., 1998; 
Ranger et al., 1998a). Nfatc1fl/fl//NFATc1-P2-Cre mice could be crossed with Tie2-
NFATc1 mice, a transgenic line which rescues the endocardial defects of Nfatc1-/- mice 
(Chang et al., 2004b). Alternatively, it could be necessary to create an inducible 
transgenic NFATc1-P2-Cre-ER line. Cre-ER is a fusion protein linking Cre recombinase 
to the ligand-binding domain of the human estrogen receptor allowing for constitutive 
expression of in active Cre-ER that becomes activated upon treatment with the estrogen 
homolog 4-hydroxytamoxifen (Metzger et al., 1995). Thus, activation of Cre in the 
developing endocardial cells would be prevented, as treatment with 4-hydroxytamoxifen 
would be postponed until after induction of AKI.  
 
Protection from renal injury 
 An additional experimental approach would be to express constitutively active 
NFATc1 in proximal tubules in an attempt to expand the population of cells that 
demonstrate accentuated NFATc1 expression. A constitutively active mutant version of 
NFATc1 (caNFATc1) was created by introducing serine to alanine mutations in the 
conserved SRR, SPXX, and SP2/3 motifs (Neal and Clipstone, 2001). However, 
interestingly ectopic expression of caNFATc1 in T cells resulted in increased gene 
expression resembling the pattern of expression observed in activated T cells without 
requiring induction events necessary for activation (Porter and Clipstone, 2002).  Ectopic 
expression of caNFATc1 has been shown to have oncogenic effects. In 3T3-L1 cells, a 
preadipocyte cell line, inhibited 3T3-L1 cells from differentiating into mature adipocytes 
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(Neal and Clipstone, 2003). 3T3-L1 cells acquired growth factor autonomy subsequently 
protecting cells from apoptosis and promoting proliferation following growth factor 
deprivation and transformed 3T3-L1 cells formed tumors when engrafted suggesting that 
NFATc1 could function as an oncogene (Neal and Clipstone, 2003). Such “oncogenic” 
effects might be advantageous to PTPCs in the face of HgCl2 induced AKI.  
 In order to express caNFATc1 in all PTCs, a new transgenic allele would need to 
be created. A clone containing a loxP-flanked stop codon followed by the caNFATc1 
coding sequence could be synthesized and inserted into the ubiquitous ROSA26 locus 
(R26R-caNFATc1). Expression of caNFATc1 would be induced in all PTCs using sglt2-
Cre and Cre activity monitored using the R26R reporter. The use of the ubiquitous 
ROSA26 locus would allow for a theoretical 1-fold increase in caNFATc1 activity in 
PTCs of R26R/R26R-caNFATc1//sglt2-Cre mice and a theoretical 2-fold increase in 
caNFATc1 activity in PTCs of R26R-caNFATc1/R26R-caNFATc1//sglt2-Cre mice. 
Proliferation markers such as PCNA, phosphorylated-histone H3 and BrdU pulse-chase 
labeling in conjunction with proximal tubule markers such as LTL and megalin would be 
used to analyze changes in the rate of proliferation of PTCs before and after AKI. We 
would expect to see a dramatic increase in proximal tubule proliferation during the period 
of postnatal development and following AKI. As caNFATc1 expression has been 
proposed to function as an oncogene (Neal and Clipstone, 2003), ectopic expression of 
caNFATc1 could result in excessive PTC proliferation in response to AKI or the 
formation of renal adenoma/carcinoma  due to hyperproliferation of the proximal tubule 
segment during postnatal development. 
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CsA nephrotoxicity 
 Knowing that genetic attenuation of one allele of Nfatc1 resulted in increased 
apoptosis and sustained AKI but not in significant changes in PTC proliferation or serum 
creatinine concentration, we sought to pharmacologically inhibit NFATc1 transcription in 
mice using the calcineurin inhibitor, CsA. Calcineurin isoforms, Aα and Aβ, were 
identified in the proximal tubule (Tumlin et al., 1995) and NFATc proteins have been 
identified in cortical tubules (Puri et al., 2004). The localization of NFATc1-calcineurin 
signaling proteins in the proximal tubule suggests that suppression of NFATc1 activity 
might contribute to the nephrotoxicity and interstitial fibrosis associated with chronic 
nephrotoxicity associated with CsA administration. However, the nephrotoxicity of CsA 
is pleiotropic having dramatic responses in endothelial, epithelial, fibroblast, and immune 
cells (Esposito et al., 2000b).   
 The important observation made in these studies is that neither low dose nor high 
dose of CsA was associated with detectable nephrotoxicity in the absence of AKI. 
However, combined treatment with CsA and HgCl2 in WT mice reduces NFATc1 
expression, elevates serum creatinine concentrations, decreases proliferation, increases 
interstitial fibrosis, and increases apoptosis in PTCs compared to WT mice treated with 
either CsA or HgCl2. Initial treatment with low and high doses of CsA showed 
characteristic morphological features of tubular epithelial injury marked by vacuolization, 
but continued treatment with CsA alone does not compound the initial damage to the 
PTCs over the brief period of our study (data not shown). Thus while, some of the 
nephrotoxicity related to administration of calcineurin inhibitors are thought to arise from 
secondary renal and systemic vasoconstriction, increased release of endothelin-1, 
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decreased nitric oxide production and increased TGF-β expression [rev. in (Olyaei et al., 
2001)], our data would suggest that CsA also renders the proximal tubule particularly 
vulnerable to toxic injuries that would otherwise be well tolerated and thus provides 
additional insights into the pathology of immunosuppressive nephropathy. 
 The toxicity and involvement of NFATc1 in proximal tubule regeneration and the 
injury from HgCl2 and CsA share a common phenotype with nephrotoxicity caused by 
the ifosfamide-metabolite chloroacetaldehyde (CAA). Ifosfamide is a commonly 
prescribed chemotherapeutic drug used both in pediatric and adult oncology with 
cytotoxic side effects including hemorrhagic cystitis and nephrotoxicity. While most 
patients report only acute nephrotoxicity, chronic nephrotoxicity can lead to the 
development of renal Fanconi syndrome, which is characterized by aminoaciduria, 
glucosuria, proteinuria, and urinary loss of phosphate and other electrolytes even after 
discontinued use (Skinner, 2003). CAA induces cell death primarily in proximal tubule 
cells through necrosis rather than through apoptosis (Schwerdt et al., 2006) and disrupts 
intracellular concentrations of calcium (Benesic et al., 2005). Interestingly, members of 
the NFAT-calcineurin signaling pathway including NFATc1 were reduced in human 
renal proximal tubule epithelial cells (hRPTEC) following exposure to CAA (Benesic et 
al., 2006). The nephrotoxicity associated with CsA and CAA confirms the importance of 
calcium homeostasis in the proximal tubule and supports a role for NFATc1 mediated 
transcriptional regulation in the proximal tubule. Thus, perturbation of NFATc1 activity 
may be a common component in the mechanism of AKI induced by multiple agents. 
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Progenitor proximal tubule population 
 Following an AKI, the precise origin of cells that proliferate in order to regenerate 
the proximal tubule segment is unknown. As discussed in Chapter I, it has been 
postulated that these cells arise from an external stem cell population circulating in the 
blood stream, adjacent less injured cells, or a resident renal stem cell population (Gupta et 
al., 2006; Morigi et al., 2006a; Sagrinati et al., 2006) (Fig. 1.2). The identification of 
renal progenitor cells has been difficult because such a population remains 
phenotypically indistinguishable from their terminally differentiated counterparts. Using 
NFATc1-P2-LacZ mice, we were able to identify a subpopulation of apoptosis resistant 
PTCs characterized by autoamplification of NFATc1 as marked by reporter activation 
and expression following HgCl2 injury. In addition, a novel transgenic reporter mouse 
line, NFATc12-P2-Cre, confirmed that the resident subpopulation of PTCs serve as a 
progenitor cell population to regenerate the damaged proximal tubule segment after 
HgCl2 induced AKI. As described in Chapter IV, less than 1% of the PTCs could be 
identified as precursor cells before AKI. This number increased to 5% by day 3 following 
HgCl2 injury and progeny of this discrete population ultimately accounted for 27% of the 
PTCs following repair at day 10 (Fig. 4.4). 
 
Role for NFATc1 in regulating quiescence and proliferation 
 As this is the first report identifying a role for NFATc1 in the proximal tubule, the 
transcriptional targets of NFATc1 in PTPCs following HgCl2 mediated AKI are 
unknown. Roles for NFATc1 in regulating quiescence and proliferation and maintenance 
of cellular integrity have been described in the formation/resorbtion of bone and in 
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controlling pancreatic β-cell mass. NFATc1 is activated and promotes proliferation of 
osteoblasts that are derived from multipotent mesenchymal progenitor cells to form new 
bone and, NFATc1 is required for the lineage specification of osteoclasts, derived from 
hematopoietic cells, to resorb bone. Calcineurin/NFATc1 signaling enhances chemokine 
expression and secretion to recruit osteoclast precursors thus stimulating proliferation and 
inhibition of the calcineurin/NFATc1 signaling pathway disrupts bone homeostasis 
causing osteopetrosis (Winslow et al., 2006). Mice with calcineurin B1 conditionally 
deleted from β-cells in the pancreas develop age-dependent diabetes and have decreased 
β-cell proliferation and mass. Constitutive nuclear expression of NFATc1 in calcineurin 
B1 null β-cells rescues the phenotype by increasing β-cell proliferation and mass. In 
addition, NFATc1 increases the expression of cell cycle regulators and β-cell genes and 
treatment with CsA to inhibit calcineurin/NFATc1 signaling caused diabetes (Heit et al., 
2006). 
 A similar mechanism may be occurring in the PTPCs: low levels of NFATc1 
expression in the PTPC population maintains cellular quiescence in the uninjured kidney 
and triggers rapid proliferation and regeneration of the proximal tubule segment 
following injury. The lineage analysis and isolation of PTPCs suggests that expression of 
NFATc1 is not induced in this population until after an injury stimulus. However, flow 
cytometry experiments suggest that prior to treatment with HgCl2, 0.3% of the defined 
cell population was GFP+ (Fig 5.2). Previously, when we quantified the percentage of 
proximal tubules that a very small percentage of cells, 0.03%, expressed NFATc1-P2-Cre 
and stained with X-Gal, prior to treatment with HgCl2. The discrepancy between these 
measurements could be due to the increased sensitivity of identifying the fluorescent GFP 
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reporter compared to enzymatic reaction and substrate staining with X-Gal to identify 
expression of β-Gal. This finding is significant as it suggests that prior to AKI, the 
NFATc1 may be active in a small population of proximal tubule cells that quiescent, a 
finding that is similar to the function of NFATc1 in maintaining the quiescence of stem 
cells of the hair follicle (Horsley et al., 2008). However, the low incidence of labeled 
cells prior to AKI would require several animals to be pooled before sorting. To further 
analyze this, GFP+ PTPCs from uninjured kidneys could be sorted and analyzed for 
DNA content to analyze progression through the cell cycle. GFP+ cells could be cultured 
in vitro, and treated with CsA, HgCl2, growth factors, or antagonists or transfected with 
gene of interest to analyze factors that balance quiescence and proliferation.  
NFATc1 expression has been recently identified in bulge cells, the stem cell 
population resident in the hair follicle, where NFATc1 retains bulge cells in a quiescent 
state (Horsley et al., 2008). Thus, the function of NFATc1 to regulate cellular quiescence 
and proliferation appears to involve different mechanisms and downstream 
transcriptional targets during normal developmental processes and during stages of 
injury. A complimentary study showed that mice with Runx1 conditionally deleted from 
keratinocytes further supports that different mechanisms control hair growth during 
development and hair growth triggered by injury (Osorio et al., 2008). Taken together, 
these studies suggest a role for NFATc1 in the maintenance of quiescence and 
proliferation of stem cells in the hair follicle.  
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Downstream targets of NFATc1 activation 
 We initiated a “candidate” gene strategy to quantify changes in expression of 
genes known to play a role in development, stem cell identity, proximal tubule 
maturation, and other renal cell populations. We used FACS analysis and qRT-PCR to 
compare the expression profiles of GFP+ PTCs, a heterogeneous population containing 
PTPCs with accentuated NFATc1 expression and their progeny, and GFP– PTCs 5 days 
after injury. Our results document that GFP+ PTCs are fully differentiated proximal 
tubules and have decreased expression of mesenchymal and glomerular markers. In 
addition, developmental markers and stem cell markers were increased in GFP+ PTCs 
compared to GFP- PTCs. In mice, CDK4 expression was increased in renal tubule 
epithelial cells during the phase of proliferation following I/R injury (Park et al., 1997). 
The increase expression of CDK4 and Nfatc1 suggest that regulation of cell cycle 
progression in PTPCs is regulated by a different mechanism than that observed in the 
bulge cells of the hair follicle (Horsley et al., 2008). We would propose a mechanism in 
which an increase in NFATc1 significantly increases BMP7 and CDK4 expression to 
synergistically release PTPCs from their quiescent slow-cycling state thus promoting 
progression through the cell cycle to regenerate the damaged proximal tubule segment. 
Furthermore, we would propose that the increased expression of stem cell markers, such 
as c-Myc, control the rate of proliferation of the PTPCs. The relationship between c-Myc 
and NFATc1 signaling has been previously studied in B-lymphocytes. C-Myc amplified 
intracellular Ca2+ concentration and promoted NFATc1-dependent proliferation, low 
levels of Ca2+ and/or c-Myc signaling alone resulted in an apoptotic response, and 
constitutive c-Myc signaling or c-Myc activation with sustained Ca2+/NFATc1 activation 
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promoted differentiation (Habib et al., 2007). The increase in c-Myc expression may 
promote proliferation and coordinate a balance between apoptosis and proliferation in 
this population. Identifying the mechanism of cell cycle regulation involving BMP7, 
CKD4, c-Myc and NFATc1 warrants further investigation. 
 As described above, our methods for isolation of GFP+ PTCs resulted in a 
heterogeneous population of cells composed of 1) the NFATc1-P2-Cre expressing 
progenitor cells and 2) constitutively labeled GFP+ progeny. Optimally, we want to 
isolate and exclusively characterize the progenitor population in the process of AKI. 
Therefore, I have developed a new transgenic line, NFATc1-Venus, using the NFATc1-
P2 enhancer element, the minimal HSP promoter, and a yellow fluorescent protein that 
localizes to the nucleus, Venus (Nagai et al., 2002). The enhanced fluorescence of this 
reporter construct should allow direct FACS isolation of the PTPC population. 
 Initial experiments will be required to confirm the expression pattern of the 
NFATc1-Venus reporter both in developing endocardial cells, as previously characterized 
for NFATc1-P2-LacZ (Zhou et al., 2005), and in the proximal tubule following HgCl2 
injury. These mice will then be used to FACS the Venus+ PTPCs before and after injury. 
The gene expression profile of the Venus+ PTPCs can be compared to the unlabeled PTC 
population by using both a candidate gene strategy as well as microarray analysis to 
survey for evidence of broad activation/repression of specific signaling cascades (cell 
cycle regulation, apoptosis, calcineurin-NFAT signaling) and to screen for novel, 
unanticipated factors that may participate in the process (stem cell, developmental, and 
novel markers). As described for the Z/EG mice, Venus+ PTPCs should have an increase 
in expression of stem cell and developmental markers, cell cycle regulatory genes 
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indicative of increased cell proliferation, and anti-apoptotic genes. Identification of 
NFATc1 transcriptional targets would facilitate a more mechanistic understanding of the 
function of NFATc1 in mediating renal injury.  
 
Are NFATc1 PTPCs restricted progenitor cells or multipotent stem cells? 
 It would be informative to determine if the NFATc1+ PTPCs are capable of 
regenerating additional components of the damaged nephron in addition to regeneration 
of proximal tubules, as described in this work. Are NFATc1+ PTPCs only progenitor 
cells or do they possess multipotent stem cell properties? The potential for NFATc1 
accentuation to identify other renal progenitor cells provides a potentially fruitful avenue 
of investigation for potential therapeutic application in regenerative medicine. NFATc1+ 
PTPCs may adopt a renal differentiation program participating in the development of all 
renal cell populations, retain an epithelial phenotype contributing to the formation of 
tubular epithelial cells, or maintain specificity of a proximal tubule cell type. To answer 
this question, isolation of the NFATc1+ PTPCs from NFATc1-Venus mice could be used 
to further test the regenerative potential of these cells by analyzing if NFATc1-
accentuated cells have the potential to regenerate other renal cell populations, thus testing 
an alternative hypothesis that adjacent less injured cells have regenerative capabilities. 
NFATc1+ PTPCs could be sorted and injected into SCID mice after HgCl2, I/R, or 
glycerol-rhabdomyolysis injury to test if they regenerate proximal and/or distal tubules, 
glomeruli, or endothelial cells and increase renal function, as performed previously 
(Gupta et al., 2006; Lazzeri et al., 2007; Sagrinati et al., 2006).  
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 NFATc1+ PTPCs could also be grafted under the renal capsule to see if they will 
form tubular segments, migrate and incorporate into host nephrons, or adopt other renal 
cell fates as performed with MRPC (Gupta et al., 2006). In addition, NFATc1+ cells 
could be microinjected into WT mouse kidney rudiments and grown in vitro for 7 to 10 
days. Similar experiments were performed with R26R ES cells and injected ES cells were 
found in tubular epithelial cell populations and in glomerular tufts (Steenhard et al., 
2005). Targets of NFATc1 activation as described above could be validated in these cells. 
Our data suggests that the PTPCs are fully differentiated and proliferate under a program 
of self-renewal to regenerate only the proximal tubule segment making this possibility 
less likely, but certainly worthy of investigation 
 
Concluding remarks 
 The data presented here show that NFATc1 plays a role in proximal tubule 
regeneration following AKI and genetic and/or pharmacologic attenuation of NFATc1 
results in increased proximal tubule apoptosis, increased renal injury, decreased 
proliferation, and even death. The most significant discovery presented in this thesis is 
the identification of NFATc1 expression in a subset of proximal tubules following HgCl2 
induced AKI, which is characteristic of a unique PTC progenitor cell population. In 
addition, we provide the first transgenic model system to identify a renal progenitor cell 
population in the proximal tubule. To our knowledge, the delayed regeneration after AKI 
is the first example of a phenotype identified in the Nfatc1+/- mouse and proposes a role 
for NFATc1 in the regeneration of injured proximal tubule cells by a resident population 
of progenitor proximal tubules accentuated by NFATc1 expression.  
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